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ABSTRACT 
DDX43, DEAD-box polypeptide 43, also known as HAGE (helicase antigen gene), is a 
member of the DEAD-box family of RNA helicases.  It is highly expressed in many tumor 
types compared with normal tissues, and is therefore considered as a potential target for 
immunotherapy of cancers.  Despite its unique expression and potential as a therapy target, 
little is known about its biochemical and physiological functions.  In this study, we purified 
recombinant DDX43 protein to near homogeneity and our gel filtration results showed that 
DDX43 exists as a monomer in solution.  Biochemical assays using monomer fractions of 
DDX43 demonstrated that it could unwind both RNA and DNA substrates in an ATP-
dependent manner, and most efficiently in the presence of Mg2+; no significant unwinding 
activity was detected with other nucleoside triphosphates or divalent cations.  Replacing the 
conserved lysine in motif I (K292A) or aspartic acid in motif II (D396A) abolished the 
unwinding activity.  Intriguingly, DDX43 could unwind RNA substrates without strict 
polarity, but it showed higher unwinding activity on a 5’ tail RNA substrate compared to a 3’ 
tail or blunt end RNA substrates.  However, for DNA substrates, it exhibited unidirectional 
translocation and unwound DNA in a 3’to 5’ direction only. A K-homology (KH) domain in 
the N-terminal region of DDX43 was found to possess strong nucleic acid binding ability and 
the N-terminal domain showed novel strand exchange and required for the unwinding activity.  
Compared to the full-length protein, the C-terminal helicase domain had weaker unwinding 
activity, but an increase was observed in the presence of the N-terminal domain.  Using Co-
immunoprecipitation and mass spectrometry, we found that DDX43 associates with pICln 
and MEP50, two methylosome subunits that are involved in assembly of the spliceosome 
complex.  Collectively, our results suggest that DDX43 is a KH domain containing ATP-
dependent dual helicase, where unwinding activity is mediated through cooperation between 
its N-terminal domain and helicase domain, and potentially involved in pre-mRNA splicing.  
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1. INTRODUCTION 
1.1 Helicases and their Functions  
Helicases are ubiquitous and integral members of almost all complexes that catalyze reactions 
of nucleic acid metabolism.  The basic reaction catalyzed by this family of enzymes is the 
unwinding of the duplex form of DNA or RNA, a process coupled to the steps of enzymatic 
nucleoside triphosphate (NTP) hydrolysis (Caruthers and McKay, 2002).  Based on their 
substrates, helicases can be classified as DNA or RNA helicases, although some can function 
on both DNA and RNA molecules (Pyle, 2008; Taylor et al., 2010).  Generally helicases move 
directionally along one nucleic acid strand and can be classified according to their 
directionality of unwinding, 5’–3’ or 3’–5’ with respect to the strand they bind to and move 
along (Patel and Picha, 2000), but they can catalyze bidirectional unwinding as well (Tuteja 
et al., 2014).  
Both DNA and RNA helicases are involved in regulation of various aspects of nucleic 
acid metabolism (Bernstein et al., 2010; Jankowsky, 2011).  DNA helicases have been 
reported to function in a variety of biochemical processes, including unwinding duplex and 
alternative DNA structures (triplex, G-quadruplex) and displacing protein bound to DNA (Wu 
and Brosh, Jr., 2012; Suhasini and Brosh, Jr., 2013).  They are also involved in other metabolic 
processes, e.g., DNA replication, meiotic recombination, DNA double-strand break repair and 
telomere maintenance (Singh et al., 2012).  DNA helicases also play multifaceted roles in 
homologous recombination (HR) and chromatin remodeling (Daley et al., 2013). 
The functions of RNA helicases are not limited to RNA strand separation, as they can 
also catalyze various RNA chaperone activities.  They can displace proteins from RNA 
molecules without duplex unwinding, anneal RNA strands, act as RNA clamps or 
placeholders, and stabilize on-pathway folding intermediates and thus regulate RNA 
metabolism (Fairman et al., 2004; Halls et al., 2007; Shibuya et al., 2004; Solem et al., 2006; 
Yang and Jankowsky, 2005).  DEAD-box proteins are members of the SF2 superfamily of 
helicases, comprised of mainly RNA helicases and are involved in virtually all aspects of 
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eukaryotic RNA metabolism. Prp5 (DDX46) (Xu et al., 2004) and p68 (DDX5) (Liu and 
Cheng, 2015) are implicated in the early events of pre-splicesomal assembly.  A large number 
of DEAD-box proteins are associated with rRNA maturation in eukaryotes and prokaryotes 
during ribosome biogenesis and comprises by far the largest number of RNA helicases of the 
DEAD box family (Liang and Fournier, 2006).  For example, two DEAD-box proteins, eIF4A 
and Ded1 from S. cerevisiae and their homologues in higher eukaryotes, are essential for 
translation initiation (Linder, 2003).  Some DEAD-box proteins are also associated with 
transcription (p68 and p72) (Fuller-Pace, 2006), nuclear export (Dbp5) (Gatfield et al., 2001), 
RNA export and RNA degradation (Dob1/Mtr4) (Anderson and Parker, 1998; Estruch and 
Cole, 2003), and in organelle gene expression (Mss116, Mrh4, Cyt-19 ) (Schmidt et al., 2002).  
 
1.2 The Mechanisms of Helicases  
Helicases unwind long stretches of duplex nucleic acids by coupling base pair separation to 
translocation to provide the single-stranded template required in many biological events, such 
as replication, recombination, and repair (Soultanas and Wigley, 2001).  To unwind substrates 
most of the helicases need a single-stranded nucleic acid region to bind and to initiate their 
action of strand separation.  Once loaded on the strand, they show a directional bias and 
translocate either 5’ to 3’ or 3’ to 5’ direction or may unwind DNA in a bidirectional manner 
(Tuteja et al., 2014). But a few helicases like RecBCD and DEAD-box helicases can initiate 
unwinding from blunt ended substrates as well (Farah and Smith, 1997).  All of these 
mechanisms involve NTPase-coupled nucleic acid affinity changes and a conformational 
change to explain biased movement that results in base pair separation or translocation (Patel 
and Donmez, 2006).  To explain the key features of the unwinding process, two catalytic 
mechanisms have been proposed referred to as active and passive. (Manosas et al., 2010).  
In the passive mechanism, the helicase behaves opportunistically.  The Helicase does not 
interact with the double strand DNA, it interacts only with single-stranded DNA (ssDNA) 
when terminal base pairs open, which occurs rapidly and spontaneously at duplex termini.  
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The Protein binds to the ssDNA, stabilizes it and physically blocks the base pair(s), and 
prevents immediate reannealing of the duplex (Fig. 1.1 A).  Because the terminal base pair at 
the junction opens and closes at a very fast rate, this type of a mechanism is attractive for 
helicases that can move and occupy one base at a time.  Also, this mechanism of unwinding 
is very efficient because the kinetics of local base pair opening are relatively fast (Nonin et 
al., 1995).  For example, Mcm 4,6,7 (30 bp) , NPH II (40 bp), unwind substrates with high 
processivity using this mechanism (Kaplan et al., 2003; Kawaoka et al., 2004; McGeoch et 
al., 2005; Hacker and Johnson, 1997) 
When the rate constants for base-pair opening are slower than the rate constants for 
helicase translocation along single-strand RNA or DNA, helicases use the active mechanism 
for the unwinding of the substrate.  In this mechanism, the helicase binds to the duplex and 
induces strand separation, an event directly coupled to its movement along the DNA and fully 
separates the strands in a unidirectional manner.  The protein could spread out over the duplex 
region and electrostatically destabilize it (Fig. 1.1 B).  Enzymes using this type of mechanism 
would translocate on ssDNA and unwind the DNA duplex at a rate comparable or identical to 
that of translocation on ssDNA (Bianco and Webb, 2012). NS3 (Cheng et al., 2007), hepatitis 
C virus (non-ring shaped helicase) (Donmez et al., 2007), and Pcr A helicase (Cheng et al., 
2002) have been proposed to use this mechanism for unwinding. 
 
1.3 Superfamily 2 Helicases 
Based on the occurrence and characteristics of conserved motifs in the primary sequence, 
helicases are categorized into six superfamilies, designated SF1–SF6 (Fig. 1.2).  Helicases of 
different families share similarities in their three-dimensional folds, with two RecA-like 
domains making up the helicase core (Subramanya et al., 1996; Bird et al., 1998).  
Structurally, two distinct types of helicases exist, those forming toroidal, predominantly 
hexameric structures, and those that do not.  The toroidal enzymes comprise SF3 to SF6, and 
the non-ring forming ones comprise SF1 and SF2 (Singleton et al., 2007).  The largest of the 
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Figure 1.1 The mechanisms for unwinding by helicases.  (A) In the passive mechanism the 
DNA fork thermally fluctuates between dsDNA and ssDNA states (step 1).  When the amount 
of ssDNA between the helicase and the junction is greater than or equal to the helicase step 
size (δ) the helicase may forward translocate (step 2).  (B) In active mechanism helicase 
destabilizes a region (the light blue cloud) of dsDNA near the junction (step 1).  This makes 
the junction more likely to be open so that the helicase is able to step forward (step 2) more 
frequently. Adapted from Pyle AM, 2008. 
six groups are the superfamily 1 and 2 helicases, most of which have a 3’-5’ directionality.  
In humans, there are at least 103 SF2 and 17 SF1 helicases, in S. cerevisiae at least 59 SF2 
and 9 SF1 helicases have been identified.  All SF1 and SF2 helicases contain Walker A and 
Walker B motifs, and typically five to seven different flanking conserved motifs.  Walker A 
motif, also known as the Walker loop or P-loop (phosphate-binding loop) has the consensus 
sequence GxxxxGK(S/T), which is associated with phosphate binding (Mercier et al., 2015).  
Helicase motifs involved in ATP binding are located at the interface between two RecA-like 
domains (Singleton and Wigley, 2002).  The two helicase domains are connected through a 
linker, which varies considerably between SF1 and SF2 proteins and also between SF2 family 
A B
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members (Caruthers and McKay, 2002).  With bound ATP and nucleic acid, the two helicase 
domains form a deep cleft.  The ATP binding site is located on one side of this cleft, and the 
nucleic acid binds on the other side, across both domains. 
All superfamilies of helicases from SF1 to SF6 show variation in terms of conserved 
motifs and their members.  In terms of number of conserved motifs, SF1 and SF2 contain two 
RecA-like domains and at least seven conserved amino acid motifs whose sequences, 
organization, and secondary structures are in general very similar (Gorbalenya et al., 1988).  
SF1 (Rep and PcrA) and SF2 (NS3) helicases differ primarily in motifs III and IV (Kim et 
al., 1998).  Members of SF3 to SF6 superfamilies are structurally different from SF1 and SF2 
helicases as they contain only one RecA-like domain and only two to five conserved motifs, 
e.g., SF3 and SF4 contains only 4 and 5 conserved sequence motifs respectively.  In terms of 
the subfamilies and members of the different superfamilies, SF2 includes several intensively 
studied subfamilies, including DEAD-box RNA helicases (Cordin et al., 2006), the RecQ-
like family (Bennett and Keck, 2004), and the Snf2-like enzymes (Flaus and Owen-Hughes, 
2004).  SF3 enzymes, usually derive from DNA or RNA viruses, e.g., SV40 and AAV. SF4, 
and SF5 include DNA helicases of bacterial origin, e.g., the transcription terminator Rho/V- 
F-ATPases (Enemark and Joshua-Tor, 2008).  MCM proteins of archaea and eukaryotes and 
RuvB branch migration enzyme belong to the SF6 (Putnam et al., 2001). 
The superfamily 2 is subdivided into at least 10 families, based on phylogenetic analysis 
of the sequences of the helicase core domains (Jankowsky and Fairman, 2007).  Five of these 
SF2 families (DEAD-box, DEAH/RHA, Ski2-like, RIG-I-like, and viral DExH proteins 
includes NS3/NPH-II family) are comprised mainly of RNA helicases and are thus termed 
‘‘RNA helicase families’’.  Out of five, three of them, DEAD box, DEAH box, and Ski2 
(Superkiller-like 2)-like share eight conserved motifs (I, Ia, Ib, II, III, IV, V and VI) and are 
collectively referred to as the DExD/H group of RNA helicases (Jankowsky and Bowers, 
2006).  These conserved motifs occupy two different domains: motifs I, Ia, Ib, II, and III in 
domain 1 (Rec A1) and motifs IV, V, and VI in domain 2 (Rec A2).  These motifs are usually 
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clustered in a region of 200–700 amino acids, called the helicase core domain. 
 
 
 
Figure 1.2 A schematic representation of the core helicase domains of helicase 
superfamilies.  The N-terminal RecA domain (RecA1) is represented by a blue cylinder and 
the C-terminal RecA domain (RecA2) is shown as a red cylinder.  Conserved amino acid 
motifs are colored according to helicase function.  Motifs in yellow are involved in NTP 
binding/hydrolysis, green are associated with translocation, and blue interact with the nucleic 
acid.  Motifs that are unique to specific superfamilies are highlighted with a red oval.  The 
Walker A (A), Walker B (B) and arginine finger (R) motifs are conserved across all helicase 
superfamilies.  Adapted from Jackson RN et al., 2014. 
These conserved motifs are important for biochemical functions of helicases.  Both motifs I 
and II are required for binding and hydrolyzing ATP. Mutations in either motif I or II result 
in enzymes that are deficient in ATPase and DNA/RNA-unwinding activities (Cordin et al., 
2006).  Motif II contains a conserved aspartate residue that is thought to bind the Mg2+ ion, 
which is required for catalysis and it also contains a conserved glutamine residue that is 
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proposed to coordinate the attacking water during ATP hydrolysis (Story et al., 2001).  Motif 
III couples ATP hydrolysis with the helicases activity and motif VI has a role in RNA binding 
and ATP hydrolysis (Pause et al., 1993).  Motifs Ia, Ib, IV, and V are less well studied, but 
there is evidence that they contribute to substrate binding (Cordin et al., 2006) (Fig. 1.3 A).  
X-ray crystallographic studies demonstrate that the conserved helicase motifs are closely 
associated with the tertiary structure of helicase proteins, suggesting that they form a large 
functional domain coordinating ATP binding and hydrolysis to nucleic acids unwinding 
(Singleton et al., 2007) (Fig. 1.3 B).  
 
1.4 DEAD-box Helicases 
The DEAD-box proteins were first identified as a distinct family in the late 1980’s when 
alignments based on eight homologues of the yeast eIF4A translation initiation factor 
highlighted the presence of several conserved motifs (Linder et al., 1989).  The name of the 
family was derived from the amino-acid sequence D-E-A-D (Asp–Glu–Ala–Asp) of its 
Walker B motif.  This key motif of DEAD-box proteins have been found in more than 500 
proteins (Silverman et al., 2003).  
 DEAD-box proteins are involved in virtually all aspects of eukaryotic RNA 
metabolism.  Several DEAD-box helicases have generated particularly high interest because 
they are involved in the multiple processes of RNA metabolism (Fuller-Pace, 2013).  
Dysregulation of RNA helicases can influence various critical processes, namely 
transcription, splicing, and translation, which may all lead to cancer (Abdelhaleem, 2004).   
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Figure 1.3. Domain architecture and X-ray structure of the SF2 superfamily helicase.   
(A) Schematic representation of the motifs found in the SF2 superfamily.  The motif II 
(Walker B) contains the DEAD (named after the amino acids Asp-Glu-Ala-Asp) box.  
Adapted from Bleichert et al., 2007.  (B) Crystal structure of the Methanococcus jannashii 
DEAD box protein.  The conserved motifs shown in are highlighted with different colors.  
The figure was created with molscript (http://www.avatar.se/molscript/) and POVRAY 
(http://www.povray.org/) using the coordinates deposited in the Protein Data Bank (1HV8).   
 
RNA helicases which are generally overexpressed in various cancers include DDX5 
(colorectal cancer), DDX47 (cervical cancer), DDX48 (gastric cancer) and DHX9 (lung 
cancer) (Causevic et al., 2001; Doorbar et al., 2000; Lee et al., 2002; Wei et al., 2004). 
DEAD-box helicases have also been implicated in tumor initiation, progression and 
maintenance (Robert and Pelletier, 2013).  These proteins generally act as components of 
multi-protein complexes and regulate cellular proliferation and/or neoplastic transformation 
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(Fuller-Pace, 2013). 
DEAD-box proteins have been found to unwind their RNA substrates by a unique 
mechanism.  Duplex unwinding by DEAD-box proteins is not based on translocation of the 
RNA substrate (Yang and Jankowsky, 2006).  Instead, DEAD-box proteins directly load to 
the duplex region, and then pry the strands apart by local destabilization in an ATP-dependent 
fashion (Yang et al., 2007).  As a result, DEAD-box proteins do not display a defined 
unwinding polarity on an RNA substrate, as distinct from many other RNA and DNA 
helicases. 
 
1.5 The KH domain 
The KH domain is an evolutionarily conserved sequence motif that was first identified in the 
human heterogeneous nuclear ribonucleoprotein K (hnRNP K) more than two decades ago 
(Matunis et al., 1992).  KH domains are approximately ~70 amino acids long with the most 
conserved consensus sequence being VIGXXGXXI, mapping to the middle of the domain 
(Gibson et al., 1993) (Fig. 1.4 A).  The K homology (KH) module is a widespread RNA-
binding motif that has been detected by sequence similarity searches in proteins as hnRNP K 
and ribosomal protein S3 (Fig. 1.4 A).  Analysis of three-dimensional structures of KH 
domains in hnRNP K (Baber et al., 1999) and S3 (Wimberly et al., 2000) reveals that they 
are topologically dissimilar and thus belong to different protein folds .  Thus KH motif 
proteins provide a rare example of protein domains that share significant sequence similarity 
in the motif regions but possess globally distinct structures (Grishin, 2001).  Sequence 
similarity in the KH motif reflects descent from a common ancestor (Burd and Dreyfuss, 
1994).  The conservation of KH motif in diverse organisms such as Bacteria, Archaea and 
Eukaryotes suggests that KH arose early in evolution.  
The KH domain exists in two different versions; type 1 KH fold (KH1) in eukaryotes and 
type 2 KH fold (KH2) in prokaryotes (Ashley, Jr. et al., 1993).  In eukaryotes, it is present in 
multiple copies, and can vary from 2 to 15 copies of the KH domain (Gibson et al., 1993; 
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Siomi et al., 1994).  In prokaryotes, the KH domain is present in single copy, for example in 
Mer1p and Sam68 (Spingola et al., 2004; Lukong and Richard, 2003).  The presence of 
multiple copies of the KH domain is a sign that it binds RNA as a multimer.  Type I and type 
II KH domains share a minimal consensus sequence motif and contain different structural 
folds with different C-terminal or N-terminal extensions giving distinct topology for type I 
and type II, respectively (Valverde et al., 2007) .  The type I KH domains have a three stranded 
anti-parallel beta-sheet packed against 3 alpha helices whereas in type II domains two of the 
three beta strands are in a parallel orientation (Fig. 1.4 B).  
Unlike RNA recognition motifs, which recognize a diversity of RNA lengths, the binding 
cleft of KH domains is versatile but accommodates only four nucleic acid bases.  In all KH 
domain-nucleic acid structures, the nucleic acid backbone interacts with a conserved GxxG 
loop that links the two helices of the minimal KH core.  The RNA or DNA is bound in an 
extended, single stranded conformation across one face of the KH domain, between the α1-
helix and the α2-helix and GXXG on the ‘left’, and the β2-sheet and the variable loop on the 
right, mainly by hydrogen bonds (Fig. 1.4 C).  This orients four nucleic acid bases towards a 
groove in the protein structure where hydrophobic interactions and a network of main-chain 
and side-chain hydrogen bonds mediate nucleobase recognition (Nicastro et al., 2015a).  The 
phosphates of the first two nucleotides are instead docked against the GxxG loop by means 
of electrostatic interactions, H-bonding and inter-molecular Van der Waals interactions, 
depending on the specific complex.  Nucleobase recognition is mediated by base-pair-like H-
bonding between the moieties on the Watson–Crick edges of the NA bases and the backbone 
and side chain of the protein (Backe, Messias et al. 2005) 
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Figure 1.4 hnRNP K homology (KH) motif and crystal structure of a KH domain bound 
to RNA.  (A) Sequence alignment of the hnRNP K motif across species.  (B) Domain 
representation of type I and type II KH domain folds.  The dotted line connecting the β2-
strand and β’-strand represents the variable loop.  The white line connecting the α1-helix and 
the α2-helix represents the GXXG loop.  (C) 3D representation of type I KH domain; the 
binding cleft comprises the secondary structural elements α1-helix, GXXG loop, α2-helix, 
β2-strand, and variable loop (colored green), and recognizes four nucleotides (cyan sticks).  
The green dotted line represents the location of the variable loop in type II KH domains.  In 
all KH domain-nucleic acid structures, the nucleic acid backbone interacts with a conserved 
GxxG loop that links the two helices of the minimal KH core.  The nucleic acid is bound in 
an extended conformation across one side of the KH domain mainly by hydrogen bonds.  This 
orients four nucleic acid bases towards a groove in the protein structure where hydrophobic 
interactions and a network of main-chain and side-chain hydrogen bonds mediate nucleobase 
recognition.  Adapted from Burd and Derfuss, 1994 and Valverde et al., 2008. 
A
B
C
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In eukaryotes, RNA-binding proteins that contain multiple KH domains play a key role  
in coordinating the different steps of RNA synthesis, metabolism, and localization (Siomi et 
al., 1994).  Sequence and structure-specific recognition of RNA targets is a hallmark of 
proteins involved in pre-messenger RNA splicing and other kinds of RNA processing (Burd 
and Dreyfuss, 1994).  KH domains in Nova2 have been found to regulate alternative splicing 
of pre-mRNA, having a specific function in the brain (Ule et al., 2005).  Thus hnRNP K-
homology (KH) domain has emerged as one of the most prevalent protein motifs responsible 
for ssRNA binding in these systems. 
 
1.6 DDX43 (HAGE) Helicase  
DDX43, DEAD-box polypeptide 43, also known as HAGE (helicase antigen gene), was first 
identified as a cancer/testis antigen gene in a human sarcoma cell line (Martelange et al., 
2000).  DDX43 belongs to the DEAD-box family of ATP-dependent RNA helicases and the 
gene is present on chromosome 6 (6q12-q13), which was determined by radiation hybrid 
analysis, and encodes a putative 73 kDa protein.  Close inspection of the DDX43 protein 
reveals that it contains the signature motifs of a SF2 RNA helicase, including Q, I, Ia, Ib, II, 
III, IV, V, and VI (Fig. 1.5A).  In addition, DDX43 also has conserved motifs Ic, Va, and Vb 
and a KH domain with its hallmark sequence of VIGXXGXXI which is present in certain 
DEAD-box proteins (Fairman-Williams et al., 2010). (Fig. 1.5 B). 
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Figure 1.5 Domains and primary protein sequence of the human DDX43 protein.  (A) 
Motifs of SF2 helicase DDX43, Conserved helicase motifs are indicated by yellow boxes, 
and three potential K homology (KH)-domain are indicated with pink.  (B) Schematic 
representation of the primary structure of DDX43. 
DDX43 mRNA is found to be expressed by a wide range of tumour tissues at levels at 
least 100-fold that of normal tissues, with the exception of the testis (Martelange et al., 2000) 
(Fig. 1.6 A).  At the protein level, DDX43 is also detected in a variety of tumour tissues 
including bladder, brain, breast, colon, esophagus, kidney, liver, lung, stomach and small 
intestine, but totally absent or expressed at very low level in normal tissues (Mathieu et al., 
2010) (Fig. 1.6 B).  DDX43 protein is also overexpressed in more than 50% of chronic 
myeloid Leukemia (CMLs), 20% of acute myeloid Leukemia (AMLs) (Adams et al., 2002), 
and more than 40% of multiple myelomas.  It is also highly expressed in melanoma (Mathieu 
et al., 2007).  DDX43 has been detected in 1650 breast cancer patients, where high expression 
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correlates significantly with aggressive clinicopathological parameters, including high 
proliferation, overexpression of both EGFR (epidermal growth factor receptor) and HER2 
(human epidermal growth factor receptor 2), and abnormal expression of p53 and p16 (Wiese 
and Pajeva, 2014).  Therefore, DDX43 is proposed to be a valid candidate for designing a 
broad spectrum vaccine against cancer.  Considering the expression pattern and the diversity 
of DDX43 expression in different tumors, DDX43 may also represent a suitable target for 
immunotherapy.  
 
DDX43 belongs to superfamily 2 RNA helicases, with seven conserved helicase 
motifs. RNA helicases are involved in gene transcription and post-transcriptional regulation, 
including pre-mRNA splicing, translation initiation/elongation, and RNA degradation 
(Cordin et al., 2006).  Their altered expression levels have also been implicated in tumour 
initiation, progression, and maintenance (Robert and Pelletier, 2013).  DDX43 functions as 
an oncogene in various biological processes.  It has been found to promote the expression of 
Neuroblastoma RAS (NRAS), an oncogenic protein, by unwinding mRNA secondary 
structures and enhancing NRAS translation (Linley et al., 2012).  It also increases the 
expression and activation of RAS in uveal melanoma cells with the GNAQ mutation, and 
mediates resistance to MEK (mitogen-activated protein kinase) inhibitors (Ambrosini et al., 
2014)  DDX43 has been found to be involved in the transcriptional repression of the tumour 
suppressor gene PML (promyelocytic leukemia), by inhibiting the activation of JAK–STAT 
(janus kinase–signal transducers and activators of transcription) pathway through the 
suppression of cytokine signaling 1 (SOCS1) in ABCB5+ (ATP-binding cassette subfamily 
B member 5) malignant melanoma-initiating cells (Mathieu et al., 2014)., thereby preventing 
anti-proliferative and pro-apoptotic functions of PML.  
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Figure 1.6 High-level expression of DDX43 in tumors.  (A) RT-PCR analysis of DDX43 
gene expression in normal tissue and tumors.  (B) DDX43 protein expression in multiple 
cancer tissue microarrays and patient-matched normal tissues determined by 
immunohistochemistry.  Immunohistochemical staining demonstrated the in vivo expression 
of DDX43 protein at a low level in bladder transitional cell carcinoma (A2) and breast 
invasive ductal carcinoma (B2); at an intermediate level in astrocytoma (C2), colon 
adenocarcinoma (D2) and lung squamous cell carcinoma (E2); at a high-level in esophagus 
small cell carcinoma (F2), kidney clear cell carcinoma (G2), hepatocellular carcinoma (H2), 
small intestine papillary adenocarcinoma (I2) and stomach adenocarcinoma (J2) but not in 
their respective matched normal tissues (A1, B1, C1, D1, E1, F1, G1, H1, I1 and J1).  Adapted 
from Martelange et al., 2001 and Mathieu et al., 2010. 
 
Thus, HAGE prevents the activation of JAK–STAT pathway responsible for the induction of 
the expression of the tumour suppressor PML.  Altogether, these observations indicate the 
role of DDX43 as an oncogene. DNA hypomethylation plays a significant role in 
tumorigenesis.  A wide range of cancer-linked hypomethylation of the genome has been found 
in almost all of the major human tumors, such as colon, gastric, lung, liver, breast, bladder, 
and ovarian cancers (Pogribny and Beland, 2009).  In a recent study, DDX43 has been found 
to be differentially methylated in schizophrenia and considered as an epigenetic marker of the 
A B
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disease (Wockner et al., 2015).  DDX43 promoters are also found to be hypomethylated in 
AML patients and thus DDX43 may be related to the pathogenesis of AML.  In AML and 
MDS (Myelodysplastic syndrome), DDX43 hypomethylation was associated with a favorable 
outcome and better survival (Lin et al., 2014; Chen et al., 2012).  In CML patients, abnormal 
hypomethylation of the DDX43 promoter was present, which was associated with DDX43 
mRNA overexpression and disease progression (Roman-Gomez et al., 2007).  During the 
development and progression of acute leukemia, DDX43 may be activated by promoter 
hypomethylation and inhibit the proliferation of specific leukemic cells.  
Altogether, the emerging picture of DEAD-box helicases depicts a large family of 
proteins which play an important role in RNA and DNA metabolism.  Also, considering its 
almost unique and specific expression in tumours, DDX43 represent one of the most 
promising groups of tumour-associated antigens identified to date.  A remarkable range of 
ATP-dependent and ATP-independent activities has been reported for DEAD-box proteins, 
but no KH domain has been reported in any helicase so far.  Thus, the knowledge of their 
biochemical activities is essential for devising physical models depicting DDX43’s functions. 
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2. HYPOTHESIS AND OBJECTIVES 
2.1 Hypothesis: We hypothesize that DDX43 is an ATP-dependent RNA helicase and 
contains a KH domain in the N-terminal that might function as assessory domain and play a 
crucial role in biochemical activities of the protein. 
 
2.2 Objectives:  
1) To characterize the enzymatic activities of recombinant DDX43 protein, including 
ATPase, nucleic acid binding, unwinding, and annealing activity. 
2) To determine the role of the KH domain in DDX43, and its functional interaction with 
the helicase domain. 
3) To examine the expression and localization of DDX43 in breast cell lines and breast 
tissues. 
4) To determine DDX43’s associated proteins by immunoprecipitation and mass 
spectrometry. 
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3. MATERIALS AND METHODS 
3.1 Reagents 
Table 3.1 List of reagents, catalog number and suppliers  
 
Reagents Suppliers Address
2-log DNA ladder, N3200L Biolab Lawrenceville, Georgia, USA
3XFLAG peptide APExBIO Houston, Texas, USA 
Acrylamide, 0314 AMRESCO North York, Ontario, Canada
N,N'-Methylenebisacrylamide Fisher Scientific Madison, Wisconsin, USA
Adenosine Triphosphate (ATP), A1852 Sigma-Aldrich Oakville, Ontario, Canada
Adenosine Diphosphate (ADP), A2754 Sigma-Aldrich Oakville, Ontario, Canada
Adenylyl-imidodiphosphate (AMP-PNP), 
A2647 Sigma-Aldrich Oakville, Ontario, Canada
Adenosine 5′-[γ-thio] triphosphate (ATP-γ-
S) Enzolifesciences Brockville, Ontario, Canada
Agarose，5510UB Gibco Burlington, Ontario, Canada
Ampicillin, A1593 Sigma-Aldrich Oakville, Ontario, Canada
Ammonium persulfate (APS), A3678 Sigma-Aldrich Oakville, Ontario, Canada
Boric Acid, SLBC5554V Sigma-Aldrich Oakville, Ontario, Canada
Bovine serum albumin Sigma-Aldrich Oakville, Ontario, Canada
Bradford protein assay reagent, 500-0013 Bio-Rad Hercules, California, USA
Bromophenol blue Sigma-Aldrich Oakville, Ontario, Canada
Chloramphenicol Fisher Scientific Madison, Wisconsin, USA
Dithiothreitol (DDT) Sigma-Aldrich Oakville, Ontario, Canada
DNAase Sigma-Aldrich Oakville, Ontario, Canada
dNTPs, N0447S NEB Mississauga, Ontario, Canada
Dulbecco's Modified Eagle Medium 
(DMEM), SH30022.01 Sigma-Aldrich Oakville, Ontario, Canada
EDTA Fisher Scientific Madison, Wisconsin, USA
ANTI-FLAG® M2 Affinity Gel Sigma-Aldrich Oakville, Ontario, Canada
Fetal Bovine Serum (FBS), F6178 Sigma-Aldrich Oakville, Ontario, Canada
Formic Acid Sigma-Aldrich Oakville, Ontario, Canada
Glycine, BP381-5 Fisher Scientific Madison, Wisconsin, USA
Glycerol, 123170 Fisher Scientific Madison, Wisconsin, USA
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 Reagents Suppliers Address
Imidazole Fisher Scientific Madison, Wisconsin, USA
Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) Fisher Scientific Madison, Wisconsin, USA
Kanamycin, 60615 Sigma-Aldrich Oakville, Ontario, Canada
Lithium chloride (LiCl) Sigma-Aldrich Oakville, Ontario, Canada
Lysogeny Broth (LB) with agar, L2897 Sigma-Aldrich Oakville, Ontario, Canada
Methanol, 154246 Fisher Scientific Madison, Wisconsin, USA
Magnesium Chloride (MgCl2) Sigma-Aldrich Oakville, Ontario, Canada
3-(N-morpholino) propanesulfonic acid 
(MOPS) Sigma-Aldrich Oakville, Ontario, Canada
Nickel-NTA Affinity beads Sigma-Aldrich Oakville, Ontario, Canada
Non-fat dry milk, 170-6404 Bio-Rad Hercules, California, USA
Nonidet P-40, 74385 Sigma-Aldrich Oakville, Ontario, Canada
N,N,N',N'-Tetramethylethylenediamine 
(TEMED), 87689 Sigma-Aldrich Oakville, Ontario, Canada
Penicillin-Streptomycin, 084M4778V Sigma-Aldrich Oakville, Ontario, Canada
Phenylmethylsulfonyl fluoride (PMSF), 
P7626 Sigma-Aldrich Oakville, Ontario, Canada
Protein standard, 161-0374 Bio-Rad Hercules, California, USA
Protease inhibitor, 05892791001 Roche Mannheim, Germany
Polyvinylidene difluoride (PVDF) GE healthcare Mississauga, Ontario, Canada
RNAase Sigma-Aldrich Oakville, Ontario, Canada
Sodium dodecyl sulfate (SDS), L3771 Sigma-Aldrich Oakville, Ontario, Canada
Sodium chloride (NaCl), S671-10 Fisher Scientific Madison, Wisconsin, USA
T4 DNA LIGASE, M0202S Biolab Lawrenceville, Georgia, USA
T4 polynucleotide kinase NEB Mississauga, Ontario, Canada
Tris, 0826 AMRESCO North York, Ontario, Canada
Tris(2-carboxyethyl)phosphine Sigma-Aldrich Oakville, Ontario, Canada
TritonTM X-100, X100 Sigma-Aldrich Oakville, Ontario, Canada
Trypsin-EDTA, T4049 Sigma-Aldrich Oakville, Ontario, Canada
Trypsin, 85450C Sigma-Aldrich Oakville, Ontario, Canada
Tryptone, TRP402.205 Bioshop Burlington, Ontario, Canada
TWEEN® 20, BP337 Fisher Scientific Madison, Wisconsin, USA
Q5® Hot Start High-Fidelity DNA 
Polymerase, M0493S NEB
Mississauga, Ontario, 
Canada
Western Blotting detection reagent, 
RPN2232 GE Health Care Little Chalfont, UK
Xylene cyanol Sigma-Aldrich Oakville, Ontario, Canada
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3.2 Plasmids DNA and Mutagenesis 
Human DDX43 cDNA clone was purchased from the SPARC BioCentre, the Hospital for 
Sick Children, Toronto, Canada. DDX43 gene (full-length, N-terminal domain, C-terminal 
helicase domain, or KH domain) was PCR amplified and cloned into the NdeI and XhoI sites 
of a pET28a vector (Novagen).  The lysine mutant in motif I K292A, the aspartic acid mutant 
in DEAD-box in motif II D396A, and KH domain mutants G46D, G84D, and G154D were 
generated with QuikChange.  Site-directed mutagenesis kit (Agilent Technologies) using 
primers listed in the table (Table 3.2).  The KH domain of Sam68 (Lukong and Richard, 
2003) was PCR amplified from a pEGFPC1-Sam68 template and cloned into the NdeI and 
XhoI sites of a pET28a vector.  All plasmids were verified by DNA sequencing.  
 
3.3 RNA and DNA Substrates 
PAGE-purified oligonucleotides were purchased from Integrated DNA Technologies and are 
listed in (Table 3.3).  For each substrate, a single oligonucleotide was 5′-end-labeled with 
[γ-32P] ATP using T4 polynucleotide kinase (NEB) at 37°C for 1 h.  Unincorporated 
radionucleotides were removed by a G25 chromatography column (GE Healthcare).  Single-
stranded DNA or RNA substrates were kept at 4°C and ready to use.  For the double-stranded 
DNA substrate, a [γ-32P]ATP-labeled oligonucleotide was annealed to a 2.5-fold excess of the 
unlabeled complementary strands in annealing buffer (10 mM Tris–HCl, pH 7.5, 50 mM 
NaCl) by heating at 95°C for 6 min and then cooling slowly to room temperature.  For double-
stranded RNA, a [γ-32P]ATP-labeled oligonucleotide was annealed to a 2.5-fold excess of the 
unlabeled complementary strands in annealing buffer (10 mM MOPS, pH 6.5, 1 mM EDTA, 
50 mM KCl) by heating at 95°C for 6 min and then cooling slowly to room temperature.  All 
double-stranded substrates were purified by PAGE isolation, and their concentrations were 
determined by liquid scintillation counting before use. 
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  Table 3.2 List of primers used in the study 
 
Restriction digestion sites and mutagenic bases are boldfaced and underlined. To design 
oligonucleotides ending with G or C, the forward primer and reverse primer may not be in 
the equal length.  
Primer Sequence (5’-3’) Used in this study
DDX43-
F-NdeI
ACGTCATATGTCCCACCACGGAGGA
GCTCCC
Froward primer to PCR amplify full-length 
DDX43 gene or its N-terminal KH domain 
for cloning in NdeI site of pET28a vector
DDX43-
R-XhoI
GCATCTCGAGATGAAACTTCTTGGG
CCTTCCTTG
Reverse primer to PCR amplify full-length 
DDX43 gene or its C-terminal helicase
domain for cloning in XhoI site of pET28a 
vector
DDX43-
NT-R-
XhoI 
GCATCTCGAGAACCTCAGGATAACA
TTGAAAG 
Reverse primer to PCR amplify DDX43 
gene N-terminal for cloning in XhoI site of 
pET28a vector
DDX43-
HD-F-
NdeI
ACGTCATATGGAAAACATTAAAAAG
GCAGG
Forward primer to PCR amplify DDX43 C-
terminal helicase domain for cloning in NdeI 
site of pET28a vector
DDX43-
G46D-F
GAGGGATATAGTGTCGACAGAGGTG
GTCGCTGG
Forward primer for site-directed mutagenesis 
of DDX43-G46D
DDX43-
G46D-R
CCAGCGACCACCTCTGTCGACACTAT
ATCCCTC
Reverse primer for site-directed mutagenesis 
of DDX43-G46D
DDX43-
G84D-F
GTTGGCGCGGTAATCGATCGTGGTG
GGTCAAAAAT
Forward primer for site-directed mutagenesis 
of DDX43-G84D
DDX43-
G84D-R
ATTTTTGACCCACCACGATCGATTAC
CGCGCCAAC
Reverse primer for site-directed mutagenesis 
of DDX43-G84D
DDX43-
G154D-F
CATTCCAACCTTCTGTTGATAAAGAT
GGAAGCACAGATAAC
Forward primer for site-directed mutagenesis 
of DDX43-G154D
DDX43-
G154D-R
GTTATCTGTGCTTCCATCTTTATCAAC
AGAAGGTTGGAATG
Reverse primer for site-directed mutagenesis 
of DDX43-G154D
DDX43-
K292A-F
CAGACTGGAACAGGAGCGACATTGT
GTTATTTA
Forward primer for site-directed mutagenesis 
of DDX43-K292A
DDX43-
K292A-R
TAAATAACACAATGTCGCTCCTGTTC
CAGTCTG
Reverse primer for site-directed mutagenesis 
of DDX43-K292A
DDX43-
D396A-F
CCTACTTGGTTTTAGCTGAAGCAGA
CAAGATG
Forward primer for site-directed mutagenesis 
of DDX43-D396A
DDX43-
D396A-R
CATCTTGTCTGCTTCAGCTAAAACCA
AGTAGG
Reverse primer for site-directed mutagenesis 
of DDX43-D396A
Sam68-
KH-F-
NdeI
ACGTCATATGGAGCCAGAGAACAAG
TACCTG
Froward primer to PCR amplify KH domain 
of Sam68 for cloning in NdeI site of pET28a 
vector
Sam68-
KH-R-
XhoI
GCATCTCGAGGGGTTCAGGTACTCC
ATTCAAG
Reverse primer to PCR amplify KH domain 
of Sam68 for cloning in XhoI site of pET28a 
vector
DDX43-
KH-F-
NdeI
ACGTCATATGCCGCTGTGTTTTGCTT
TGAAG
Forward primer to PCR amplify DDX43 
gene N-terminal KH domain for cloning in 
NdeI site of pET28a vector
DDX43-
KH-F-
XhoI
GCATCTCGAGTTCTGAATTGTAATTT
TCTT C
Reverse primer to PCR amplify DDX43 
gene N-terminal KH domain for cloning in 
XhoI site of pET28a vector
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Table 3.3 List of RNA and DNA substrates used in the study 
 
Substrate name Structure or description Nucleotide sequence (5’→3’) 
5’ tailed dsRNA (13 
bp)
RNA-13B: GCGUCUUUACGGU
RNA-41B: 
AAAACAAAACAAAACAAAACAAAAUAGCACCGUA
AAGACGC
3’ tailed dsRNA 
(13 bp)
RNA-13A: ACCGUAAAGACGC
RNA-41A: 
GCGUCUUUACGGUGCUUAAAACAAAACAAAA
CAAAACAAAA
Blunt-end dsRNA (13 
bp)
RNA-13B: GCGUCUUUACGGU
RNA-13A: ACCGUAAAGACGC
5’ tailed dsRNA (16 
bp)
RNA-16B: GCGUCUUUACGGUGCU
RNA-41B: 
AAAACAAAACAAAACAAAACAAAAUAGCACC
GUAAAGACGC
Blunt end DNA:RNA 
hybrid (13 bp)
DNA-13A: ACCGTAAAGACGC
RNA-13B: GCGUCUUUACGGU
3’ tailed DNA:RNA 
hybrid (13 bp)
DNA-41A: 
GCGTCTTTACGGTGCTTAAAACAAAACAAAA
CAAAACAAAA
RNA-13A: ACCGUAAAGACGC
Fork dsDNA (19 bp) DC26: 
TTTTTTTTTTTTTTTTTTTTTTCCCAGTAAAACGA
CGGCCAGTGC
Tstem25: 
GCGGTCCCAAAAGGGTCAGTGCTGGCATTTTGCT
GCCGGTCACG
5’ tailed dsDNA (19 
bp)
DC26: 
TTTTTTTTTTTTTTTTTTTTTTCCCAGTAAAACGA
CGGCCAGTGC
TSTEM:GCACTGGCCGTCGTTTTAC
3’ tailed dsDNA (19 
bp)
DC: GTAAAACGACGGCCAGTGC
Tstem25:  
GCGGTCCCAAAAGGGTCAGTGCTGGCATTTTGCT
GCCGGTCACG
Blunt-end dsDNA (19 
bp)
DC: GTAAAACGACGGCCAGTGC
TSTEM:GCACTGGCCGTCGTTTTAC
Fork dsDNA (30 bp) Fork 30/15-T: 
TTTTTTTTTTTTTTTGGTGATGGTGTATTGAGT
GGGATGCATGCA
Fork 30/15-B: 
TGCATGCATCCCACTCAATACACCATCACCTT
TTTTTTTTTTTTT
Fork dsDNA (40 bp) Fork 40/15-T: 
TTTTTTTTTTTTTTTACGAGCTAAATTAGAGC
GACTGCACAACTGTAAGGTCCGT
Fork 40/15-B: 
ACGGACCTTACAGTTGTGCAGTCGCTCT
AATTTAGCTCGTTTTTTTTTTTTTTTT
3’Tail plasmid triplex The duplex plasmid DNA is prepared above. 3′ tail TC30 is 
used as third strand.
5’Tail plasmid triplex The duplex plasmid DNA is prepared above. 5′ tail TC30 is 
used as third strand.
dT30 Used as ssDNA TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
DNA-30 mer Used as a ssDNA random sequence GAGCTACCAGCTACCCCGTATGTCAGAGAG
RNA-30 mer Used as a ssRNA random sequence GAGCUACCAGCUACCCCGUAUGUCAGAGAG
13B
41B5’ 3’
13A
41A3’ 5’
13B
13A
16B
41B5’ 3’
13B
13A
13A
41A3’ 5’
19
26
1925
DC26
Tstem25
5’
3’
19
26
19
DC26
Tstem
5’
19
1925
DC
Tstem253’
19
19
DC
Tstem
5’
3’
3015
5’
3’
4015
5’*
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3.4 Expression and Purification of Recombinant DDX43 Protein 
The plasmid, pET28a-DDX43 was transformed into Rosetta 2 cells (EMD Millipore).  
Recombinant His-tagged proteins were subjected to a two-step purification using Nickel 
Affinity beads (Sigma) and a Sephacryl S-300 HR 16/60 gel filtration column (GE 
Healthcare).  The Rosetta 2 cells harboring the recombinant gene were grown at 37°C in LB 
medium containing 30 μg/mL kanamycin and 34 μg/mL of chloramphenicol until the A600 
reached 0.6 and then induced by addition of 0.3 mM IPTG for overnight expression at 15°C.  
The cells were harvested by centrifugation at 5000 g for 10 min at 4°C and stored at -80°C 
until used.  The cell suspension was lysed by sonication in buffer A (25 mM Tris pH 8.0, 0.15 
M NaCl, 100 µM Tween 20 and 10% glycerol) having final concentration of 1 mM 
phenylmethylsulfonyl fluoride (PMSF), protease inhibitor (Roche Applied Science) of at 4°C, 
with 5 short burst of 10 sec at the intervals of 5 min.  The lysed cells were centrifuged at 
45,000 g for 30 min at 4°C.  The supernatant was applied to the Ni-NTA beads equilibrated 
with buffer A.  The beads were then washed with 10 column volumes (CV) of wash buffer B 
(25 mM Tris pH 8.0, 0.5 M NaCl, 100 µM Tween 20 and 10% glycerol) containing 25 mM 
imidazole and the proteins then eluted with 5 CV of elution buffer B containing 250 mM 
imidazole.  The protein fractions were confirmed with SDS-PAGE, and fractions with high 
protein yield were pooled and subjected to size-exclusion chromatography on a Sephacryl S-
300 HR 16/60 equilibrated with buffer A.  The protein fractions were collected at a flow rate 
of 0.5 mL/min with the same buffer.  The protein was confirmed with SDS-PAGE and the 
fractions in the peak were pooled and concentrated.  Protein concentration was determined 
by the Bradford method using bovine serum albumin (BSA) as the standard. 
 
3.5 Western Blot 
Proteins (30 µg) were denatured at 100°C for 5 min, then resolved on 10% polyacrylamide 
Tris-glycine SDS gels, and transferred to PVDF membranes.  The membrane was blocked in 
PBS containing 5% skimmed milk at room temperature for 1 h, followed by probing with a 
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rabbit polyclonal anti-DDX43 antibody (1:1000, cat# HPA031381, Sigma), or a mouse anti-
His-tag monoclonal antibody (1:5000, cat# SAB1400618, Sigma), respectively.  Goat anti-
rabbit or goat anti-mouse IgG- horseradish peroxidase conjugate (cat#sc-2004, Santa Cruz 
Biotech) were used as secondary antibody at a 1:10,000 dilution and detected using ECL Plus 
(GE Healthcare). 
 
3.6 Helicase Unwinding Assays 
The helicase assay reaction mixtures (20 μL) contained 40 mM Tris (pH 8.0), 0.5 mM 
magnesium chloride (MgCl2), 0.15 mM sodium chloride (NaCl), 0.01% Nonidet P-40, 0.1 
mM DTT, 1 mg/mL bovine serum albumin (BSA), equimolar mixture of 2 mM ATP and 
MgCl2, 0.5 nM of the specified duplex RNA and DNA substrate, and the indicated 
concentrations of DDX43 protein.  Helicase reactions were initiated by the addition of 
DDX43 and incubated at 37°C for 15 min unless otherwise indicated.  Reactions were 
quenched by addition of 20 μL of 2×stop buffer (17.5 mM EDTA, 0.3% SDS, 12.5% glycerol, 
0.02% bromphenol blue, 0.02% xylene cyanol).  For standard duplex RNA and DNA 
substrates, a 10-fold excess of the unlabeled oligonucleotide with the same sequence as the 
labeled strand was included in the quench to prevent reannealing.  Reaction products of 
duplex RNA substrates were resolved on nondenaturing 15% (19:1 
acrylamide:bisacrylamide) polyacrylamide gels and products of DNA unwinding reactions 
were resolved on nondenaturing 12% (19:1 acrylamide:bisacrylamide) polyacrylamide gels.  
Radiolabeled RNA and DNA species in polyacrylamide gels were visualized using a 
PhosphorImager and quantitated using Quantity One software (Bio-Rad). 
 
3.7 Translocase Assays 
The triplex helicase assay reaction mixtures (20 μL) contained 40 mM Tris (pH 8.0), 0.5 mM 
magnesium chloride (MgCl2), 0.15 mM sodium chloride (NaCl), 0.01% Nonidet P-40, 0.1 
mM DTT, 1 mg/mL bovine serum albumin (BSA), equimolar mixture of 2 mM ATP and 
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MgCl2, 0.5 nM of the specified 5’-tail and 3’-tail plasmid-triplex substrate, and the indicated 
concentrations of DDX43 protein.  Helicase reactions were initiated by the addition of 
DDX43 and incubated at RT for 30 min unless otherwise indicated.  Reactions were quenched 
by addition of 10 μL of 2×stop buffer (17.5 mM EDTA, 0.3% SDS, 12.5% glycerol, 0.02% 
bromphenol blue, 0.02% xylene cyanol).  The products of the helicase reactions for triplex 
DNA substrates were resolved on 10% (19:1 acrylamide:bisacrylamide) polyacrylamide gels 
with 40 mM Tris acetate (pH 5.5) and 25% glycerol and running buffer containing 40 mM 
Tris acetate, pH 5.5, and 5 mM MgCl2.  Radiolabeled species in polyacrylamide gels were 
visualized using a PhosphorImager and quantitated using Quantity One software (Bio-Rad). 
 
3.8 Annealing Assay 
The reaction (20 µL) was carried out with 0.5 nM of radiolabeled 19 bp forked dsDNA.  The 
substrate was denatured first at 100°C for 5 minutes and then incubated with 0 to 3 µM of 
DDX43 protein at 370C for 15 min with or without 2 mM ATP.  After incubation the reaction 
was stopped by addition of equal volume of 2×stop buffer (17.5 mm EDTA, 0.3% SDS, 
12.5% glycerol, 0.02% bromophenol blue, 0.02% xylene cyanol).  The mixture was resolved 
on 12% native PAGE gel for 2 h at 180 V.  The resolved radiolabeled species were visualized 
using Phosphor-Imager (Bio-Rad) and analyzed using Quantity One software (Bio-Rad).  
 
3.9 Strand Exchange Assay 
The Strand exchange assay was performed in the same manner as the helicase unwinding 
assay, except cold oligo was included in the reaction.  The reaction mixture (20 μL) for the 
assay contained 40 mM Tris (pH 8.0), 0.5 mM magnesium chloride (MgCl2), 0.15 mM 
sodium chloride (NaCl), 0.01% Nonidet P-40, 0.1 mM DTT, 1 mg/mL bovine serum albumin 
(BSA), equimolar mixture of 2 mM ATP and MgCl2, 0.5 nM of the specified duplex DNA 
substrate.  The reaction was initiated by the addition of DDX43 and incubated at 37°C for 15 
min unless otherwise indicated.  Reactions were quenched by addition of 20 μL of 2×stop 
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buffer (17.5 mM EDTA, 0.3% SDS, 12.5% glycerol, 0.02% bromphenol blue, 0.02% xylene 
cyanol).  Products of DNA strand exchange activity were resolved on nondenaturing 12% 
(19:1 acrylamide:bisacrylamide) polyacrylamide gels. 
 
3.10 Electrophoretic Mobility Shift Assay (EMSA) 
Protein/DNA or RNA binding mixtures (20 µL) contained the indicated concentrations of 
DDX43 and 0.5 nM of the specified 32P-end-labeled DNA substrate in the same reaction 
buffer as that used for helicase assays (see above) without ATP.  The binding mixtures were 
incubated at room temperature for 30 min after the addition of DDX43.  After incubation, 3 
µL of loading dye (74% glycerol, 0.01% xylene cyanol, 0.01% bromphenol blue) was added 
to each mixture, and samples were loaded onto native 5% (19:1 acrylamide/bisacrylamide) 
polyacrylamide gels and electrophoresed at 200 V for 2 h at 4°C using 1×TBE as the running 
buffer.  The resolved radiolabeled species were visualized using a PhosphorImager and 
analyzed with Quantity One software (Bio-Rad). 
 
3.11 ATP Hydrolysis Assays 
ATP hydrolysis was measured using [γ-32P] ATP (PerkinElmer Life Sciences) and analyzed 
by thin layer chromatography (TLC) on polyethyleneimine-cellulose plates (J.T. Baker).  The 
standard reaction mixture (50 µL total volume) containing 40 mM Tris (pH 8.0), 0.5 mM 
MgCl2, 0 15 mM NaCl, 0.01% Nonidet P-40, 0.1 mM DTT, 1 mg/mL BSA, 250 μM [γ-32P] 
ATP, 2.5 µM DDX43 protein, ssDNA dT30 or ssRNA rU30 stimulator (0 to 10 mM), was 
incubated at 37°C for 30 min.  Reactions were quenched with 50 mM EDTA final 
concentration.  The reaction mixture was spotted onto a PEI-cellulose TLC plate and resolved 
by using 0.5 M LiCl, 1 M formic acid as the carrier solvent.  The TLC plate was exposed to 
a phosphorimager cassette for 30 min and visualized using a Phosphor-Imager and analyzed 
with Quantity One software (Bio-Rad). 
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3.12 Cell Culture 
The cells were cultured in 10-cm petri dishes under conditions of 5% CO2 and 37°C.  Unless 
otherwise stated, all cell lines were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) media (Cat# 12-604F, Lonza), supplemented with 10% fetal bovine serum (Cat# 
F1051, Sigma), 50 µg/mL penicillin streptomycin (Cat# P4333, Sigma).  For subculture, cells 
were detached from the plate floor by trypsinization.  Cells were subcultured 2-3 times per 
week at a dilution of 1:5 - 1:20, depending on the cell line.  The working area was 
decontaminated with 70% ethanol before and after use and cell culture work was performed 
under sterile conditions. 
 
3.13 Immunoprecipitation  
HEK293T cells cultured in 10-cm plates were transfected with DNA (pcDNA-3XFLAG-
DDX43) using 1% polyethyleneimine ‘Max’ (PEI) at a ratio of 1:4. For each plate, 10 μg of 
the appropriate DNA was mixed with 500 μL of 0.15 M sterile NaCl via gentle vortex for 10 
sec.  Then 40 μL of the transfection reagent, PEI, was added to this mixture followed by 
another 10 sec of a gentle vortex. DNA–PEI complex was formed by incubating the mixture 
at room temperature for 10 min followed by dispensing the complex dropwise into the plates.  
The cells were incubated for 24 h post transfection before harvest.  For immunoprecipitation, 
cells were washed in cold PBS, and lysed in freshly prepared lysis buffer constituting 20 mM 
Tris (pH 8.0), 0.5 % Nonidet P-40, 100 mM NaCl, 2 mM EDTA, 1 mM PMSF and protease 
inhibitors 0.5 µg/mL of DNAase and RNAase for 30 min followed by centrifugation for 30 
min at 40,000 g at 4°C.  Supernatants were collected into fresh tubes and incubated with anti-
FLAG resin (Sigma) and maintained on a rotator for 1 h at 4°C.  The beads were washed with 
lysis buffer for 3 times and incubated with elution buffer constituting 25 mM Tris (pH 7.4), 
0.01 % Nonidet P-40, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1 mM DTT, 1 mM TCEP, 
protease inhibitor, and 150 µg/mL 3XFLAG peptide.  The immunoprecipitated proteins were 
resolved on 10% gradient SDS-PAGE (Bio-Rad) and visualized by silver staining.  The 
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identities of excised bands were determined by the mass spectrometry service at the 
University of Alberta. 
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4. RESULTS 
4.1 Protein Overexpression and Purification 
4.1.1 DDX43 Protein Exists as a Monomer in Solution 
To characterize the DDX43 protein, we cloned the human DDX43 gene into a pET28a vector, 
overexpressed it in E. coli. and purified it by two-step chromatography.  First, the His-tagged 
DDX43 protein was passed through a Ni-NTA affinity chromatography, and the retained 
proteins were eluted with imidazole.  The recombinant DDX43 proteins were purified to near 
homogeneity as judged by their appearance on coomassie-stained SDS-polyacrylamide gel 
(Fig. 4.1 A).  The fractions with high protein concentration were pooled and applied to a 
Sephacryl S-300 size exclusion column.  DDX43 protein eluted in two major peaks, namely 
peak 1 and peak 2 (Fig. 4.1 B).  Identical migration bands were observed on the coomassie 
stained SDS-PAGE gel for these two peaks (Fig. 4.1 C).  The identity of the DDX43 protein 
was confirmed by Western blot using anti-DDX43 and anti-His antibodies respectively (Fig. 
4.1 D), indicating both fractions are indeed DDX43 protein.  According to the molecular mass 
standards used to calibrate the size exclusion column, peak 1 was in the void volume of the 
column, likely representing aggregated DDX43 protein, while the mass of peak 2 was about 
67.4 ± 5.1 kDa, which is close to the predicted monomeric form of DDX43 (72.4 kDa).  
Therefore, we collected the monomer fractions of DDX43 for the following biochemical 
assays. 
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Figure 4.1 Purification and identification of DDX43 protein.  (A) SDS-PAGE analysis of 
the eluted DDX43 fractions from a Ni-NTA column. M, marker. Fractions 3-9 are shown.  (B) 
Chromatographic profiles of recombinant DDX43 proteins eluting from a Sephacryl S-300 
HR column. Two peaks are indicated.  (C) SDS-PAGE analysis of the peaks shown in B.  (D) 
Western blot analyses of the proteins shown in C with antibody against DDX43 (left) or His 
(right). 
 
4.2 DDX43 Protein Unwinds RNA Substrates 
4.2.1 DDX43 Protein Preferably Unwinds RNA in a 5’ to 3’ Direction 
According to its primary sequence, DDX43 belongs to the DEAD-box RNA helicase family, 
thus, I started to characterize its RNA unwinding activity.  Using a 5’tail 13-bp duplex RNA,  
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Figure 4.2 RNA helicase assays of recombinant DDX43 proteins.  (A) A representative 
image of helicase reactions performed by incubating 0.5 nM 5’ tail 13 bp duplex RNA 
substrate with increasing protein concentration (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM) at 37 °C 
for 15 min.  (B) A representative image of helicase reactions performed by incubating 0.5 nM 
5’ tail 13 bp duplex RNA substrate and 150 nM DDX43 protein with increasing time (0-30 
min) at 37 °C. (C, D)  Representative images of helicase reactions performed by incubating 
0.5 nM 3’ tail 13-bp duplex RNA substrate (C) and blunt-end 13 bp duplex RNA substrate 
(D) with increasing protein concentration (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM) at 37 °C for 15 
min.  (E) Quantitative analyses of RNA unwinding of DDX43 in panel A, C and D.  Data 
represents the mean of at least three independent experiments with SD indicated by error bars. 
NE, no enzyme; WT, wild-type; filled triangle, heat denatured substrate control. 
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I found that DDX43 could efficiently unwind the substrate in the presence of ATP in both a 
concentration (0-3 µM) and time-dependent manner (0-30 min) (Fig. 4.2 A and B).  However, 
it exhibited poor unwinding activity on both a 3’ tail 13-bp duplex RNA (Fig. 4.2 C) and 
blunt end RNA substrate (Fig. 4.2 D).  These results indicated that DDX43 unwinds RNA 
substrates irrespective of the single strand overhang but with a strong preference for 5’ tail 
RNA substrate. 
 
4.2.2 DDX43 Protein Exhibits Low Processivity on RNA Substrates 
In general, DEAD-box helicases have been found to have low processivity on the RNA 
substrate (Jankowsky and Fairman, 2007).  Thus to examine the processivity of DDX43 on 
RNA substrates, I increased the length for the duplex RNA substrate from 13 bp to 16 bp 
under the same reaction conditions and observed that DDX43 almost failed to unwind the 
longer substrate.  These results indicated that DDX43 has low processivity on longer RNA 
substrates (Fig. 4.3). 
 
 
 
Figure 4.3. Helicase assay for processivity of recombinant DDX43 proteins on an RNA 
substrate.  A representative image of helicase reactions performed by incubating 0.5 nM 5’ 
tail 16 bp duplex RNA substrate with increasing protein concentration (0.09, 0.18, 0.37, 0.75, 
1.5, 3 µM) at 37 °C for 15 min. Filled triangle, heat denatured substrate control. 
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4.3 DDX43 Protein Unwinds DNA Substrates 
4.3.1 DDX43 Protein Unwinds DNA in only 3’ to 5’ Direction 
Many helicases have been found to possess dual unwinding activity using both DNA and 
RNA substrates (Kawaoka and Pyle, 2005).  Thus next we asked whether DDX43 can work 
on DNA substrates. 
 
Figure 4.4 DNA helicase assays of recombinant DDX43 proteins.  (A) A representative 
image of helicase reactions performed by incubating 0.5 nM 19-bp forked duplex DNA 
substrate with increasing protein concentration (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM) at 37 °C 
for 15 min.  (B) A representative image of helicase reactions performed by incubating 0.5 nM 
19-bp forked duplex DNA substrate and 150 nM DDX43 protein with increasing time (0-30 
min) at 37 °C.  (C, D) Representative images of helicase reactions performed by incubating 
0.5 nM 3’ tail 19-bp duplex DNA substrate (C) or 5’ tail 19-bp forked duplex DNA substrate 
(D) or blunt-end 19-bp duplex DNA substrate (E) with increasing protein concentration (0.09, 
0.18, 0.37, 0.75, 1.5, 3 µM) at 37 °C for 15 min. Filled triangle, heat denatured substrate 
control. (F) Quantitative analyses of DNA unwinding of DDX43 in panel A and C Data 
represents the mean of at least three independent experiments with SD indicated by error bars. 
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Using a 19-bp forked duplex DNA substrate, we detected that DDX43 can efficiently 
unwind the DNA substrate in the presence of ATP in both a concentration (0 – 3 µM) and 
time-dependent manner (0 - 30 min) (Fig. 4.4 A and B).  Furthermore, we found that DDX43 
was active on a 3’ tail 19-bp duplex DNA substrate, but not a 5’ tail or blunt-end substrate 
(Fig. 4.4 C-E), indicating that DDX43 translocates in the 3’-5’ direction on a DNA substrate. 
 
4.3.2 DDX43 Protein Exhibits High Processivity on DNA Substrates 
Although DDX43 possess low processivity on the RNA substrates, processivity of helicases 
are important for helicase function in DNA replication and other cellular functions.  Thus we 
aimed to examine the processivity of DDX43 on DNA substrates and we found that DDX43 
had very high processivity on DNA substrate as it could efficiently unwind 30 bp and 40 bp 
forked duplex substrates in a similar fashion (Fig. 4.5 A and B). 
 
 
 
Figure 4.5 Helicase assays for processivity of recombinant DDX43 proteins on DNA 
substrate.  (A, B) Representative images of helicase reactions performed by incubating 0.5 
nM 30-bp forked duplex DNA substrate (A) 40-bp forked duplex DNA substrate (B) with 
increasing protein concentration (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM) at 37 °C for 15 min.  Filled 
triangle, heat denatured substrate control. 
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activity of helicases, including AddAB (Gilhooly and Dillingham, 2014), FANCJ (Meetei et 
al., 2005; Sommers et al., 2009) and ChlR1 (Guo et al., 2015).  In this assay, a triple helix is 
formed when a third strand forms Hoogsteen base pairs with duplex DNA.  If a translocase 
proceeds through the triplex, it will displace the third strand.  Indeed, DDX43 could not 
displace a 5’ tailed triplex, (Fig. 4.6 A); but it could displace a 3’ tailed triplex in 3’ to 5’ 
direction, which indicates that DDX43 possess translocase activity. (Fig. 4.6 B). 
 
 
Figure 4.6 Triplex assays of recombinant DDX43 proteins.  (A-B) A representative image 
of a triplex assay performed by incubating 5’ tail plasmid-triplex (A) and 3’ tail plasmid-
triplex substrate with increasing protein concentration (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM) at 
RT for 30 minutes (B).  ChlR1 was used as a positive control. Filled triangle, heat denatured 
substrate control. 
 
4.5 DDX43-K292A and D396A Mutants Abolish Helicase Unwinding 
Activity 
To confirm that the unwinding activity detected was truly dependent on DDX43 and 
not because of contaminants in the preparation of the DDX43 protein, we changed the 
conserved lysine to alanine (K292A) in motif I, which is essential for ATP binding and 
hydrolysis, and aspartic acid to alanine in motif II of the DEAD-box (D396A), which helps 
to bind cation for enzyme activity (Fig. 1.5 A).  Under identical methods and conditions as 
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wild-type DDX43, the mutant proteins were purified to near homogeneity (Fig. 4.7 A). 
Helicase assays revealed that neither K292A nor D396A displayed any unwinding activity on 
the 5’ tailed 13 bp duplex RNA (Fig. 4.7 B and C) and 19 bp forked DNA substrate (Fig. 4.7 
D and E). 
  
  
 
Figure 4.7 Purification and characterization of mutants K292A and D396A.  (A) SDS-
PAGE analysis of DDX43 K292A and D396A proteins eluting from a Sephacryl S-300 HR 
column.  (B, C) Representative images of helicase reactions performed by incubating 0.5 nM 
5 tail 13 bp duplex RNA substrate with increasing protein concentration of K292A (B) or 
D396A (C) at 37 °C for 15 min.  (D, E) Representative images of helicase reactions performed 
by incubating 0.5 nM 19 bp forked dsDNA substrate with increasing protein concentration of 
K292A (D) or D396A (E) at 37 °C for 15 min. Filled triangle, heat denatured substrate control. 
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4.6 DDX43 Protein Unwinds DNA:RNA hybrid Substrates 
Some DEAD-box helicases have been found to unwind DNA-RNA chimeric substrates as 
well, e.g., Ded1 (Yang and Jankowsky, 2006) and DDX1 (Li et al., 2008).  Thus we asked 
whether DDX43 could unwind DNA:RNA hybrid substrates.  Using a blunt end 13bp 
DNA:RNA hybrid substrate, we detected that DDX43 protein could unwind a substrate in a 
concentration (0 – 3 µM) dependent manner in the presence of the ATP (Fig. 4.8).  
 
 
 
Figure 4.8 Unwinding activity of DDX43 protein on a DNA:RNA hybrid.  A 
representative image of helicase reactions performed by incubating 0.5 nM 5’ end labelled 13 
bp DNA:RNA blunt-end hybrid substrate with increasing protein concentration (0.09, 0.18, 
0.37, 0.75, 1.5, 3 µM) at 37 °C for 15 min.  Filled triangle, heat denatured substrate control. 
 
4.7 ATP Hydrolysis and Mg2+ are Essential for the Unwinding Activity of 
DDX43 Protein 
Helicases are motor proteins that couple conformational changes induced by ATP binding and 
hydrolysis with unwinding of duplex nucleic acids (von Hippel and Delagoutte, 2001).  To 
check whether ATP analogs can cause this conformational change in DDX43, I used non-
hydrolyzable ATP-analogs, ATP γ S and AMP-PNP and some other ATP analogs to detect the 
unwinding activity. 
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Figure 4.9 RNA and DNA helicase activity of recombinant DDX43 protein in presence 
of different NTP’s and their analogues.  (A-B) A representative images of helicase reactions 
performed by incubating 0.5 nM 5’ tail 13 bp duplex RNA substrate with 150 nM DDX43 
protein at 37 °C for 15 min with different nucleoside-triphosphate (A) or ATP or ATP analogs 
(B).  (C-D) A representative image of helicase reactions performed by incubating 0.5 nM 5’ 
tail 19 bp forked DNA Substrate with 150 nM DDX43 protein at 37 °C for 15 min with 
different nucleoside-triphosphate (C) or ATP or ATP analogs (D). Filled triangle, heat 
denatured substrate control. 
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presence of ATP but it did not exhibit any unwinding activity with ATP γ S or AMP-PNP, 
indicating ATP hydrolysis is essential for the unwinding activity of DDX43.Along with the 
ATP, the presence of a divalent cation in the helicase core of the enzyme plays a very 
important role in its unwinding activity (Frick et al., 2007). 
 
 
 
Figure 4.10 Optimized cation and ATP for DDX43 helicase activity.  (A, B) Representative 
images of helicase reactions performed by incubating 0.5 nM 5’ tailed 13 bp duplex RNA (A) 
or 19 bp forked duplex DNA substrate (B) with indicated cations (2 mM) at the protein 
concentration of 3 µM at 37°C for 15 min.  (C, D) Representative images of helicase reactions 
performed by incubating 0.5 nM 5’ tailed 13 bp duplex RNA (C) or 19 bp forked duplex DNA 
substrate (D) with indicated ATP:Mg2+ ratio at the protein concentration of 3 µM at 37°C for 
15 min. Filled triangle, heat denatured substrate control. 
To determine which cation is the best co-factor for DDX43, we performed helicase 
assays with both duplex RNA and DNA in the presence of different divalent cations.  Out of 
eight cations tested (all at 2 mM), Mg2+ was found to be the best cation for the helicase activity 
of DDX43 (Fig. 4.10 A and B).  Further, we wanted to determine the optimal ATP: Mg2+ 
ratio for the unwinding activity of DDX43.  As shown in (Fig. 4.10 C and D), ATP: Mg2+ 
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ratios of 1:1 and 1:2 were best for DDX43 unwinding activity. 
 
4.8 DDX43 Protein Does not Possess Annealing Activity  
A few DEAD-box RNA helicases promote not only RNA unwinding but also strand 
annealing.  For example, nucleolar RNA helicase 2 (RH2; also known as Gu) and DDX21 
shows annealing activity. (Uhlmann-Schiffler et al., 2006; Yang and Jankowsky, 2005; Halls 
et al., 2007).   
 
 
Figure 4.11 Annealing activity of DDX43 protein.  (A-B) A representative image of 
annealing reactions performed by incubating 0.5 nM 5’ tail 13 bp duplex RNA substrate (A) 
or 19 bp forked duplex DNA substrate (B) with increasing protein concentration (0.09, 0.18, 
0.37, 0.75, 1.5, 3 µM) at 37 °C for 15 min, with and without ATP. Filled triangle, heat 
denatured substrate control. 
I evaluated the annealing activity of the DDX43 using 5’ tail 13 bp duplex RNA and 
19 bp forked dsDNA in concentration-dependent manner (0 to 3 µM), with and without ATP.  
At first, the respective substrates were denatured at 100°C for 5 min and then incubated with 
0 to 3 µM of DDX43 protein at 37°C for 15 min.  Our results indicated that DDX43 does not 
possess annealing activity on both 13 bp duplex RNA (Fig. 4.11 A) or 19 bp forked duplex 
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DNA substrate (Fig. 4.11 B). 
 
4.9 Role of the N-terminal Accessory domain of DDX43 Protein 
4.9.1 The KH domain in the N-terminus is involved in Nucleic Acid Binding 
From its primary sequence, DDX43 contains three potential KH domains that have the 
signature GXXG motif (Fig. 1.5 B).  Also because a KH domain is approximately ~70 amino 
acids long, we cloned the KH domains-containing the N-terminal region (1-253 aa, named 
DDX43NT) into a pET28 vector for protein production.  Previous studies have shown that the 
first glycine residue in the GXXG motif is essential for the RNA binding function of various 
KH domains (Barnes et al., 2015; Lewis et al., 2000; Zhou et al., 2002), thus, we changed the 
glycine to aspartic acid in each motif, namely G46D, G84D, and G154D.  Three mutant 
proteins were purified along with wildtype to near homogeneity (Fig. 4.12 A).  Using the 19 
bp forked duplex DNA substrate, EMSA revealed that G46D and G154D bound DNA similar 
to or even tighter than wild-type protein (Fig. 4.12 B); however, the G84D mutation 
(DDX43NT(G84D)) abolished its binding activity.  Similar results were obtained with an ssRNA 
substrate and ssDNA (Fig. 4.12 C and D).  However, none of them bound blunt-end dsDNA 
(Fig. 4.12 E). 
On the other hand, close inspection of the second KH motif revealed that it has an 
additional conserved KH domain sequence VIGXXGXXI, shared with some well-known KH 
domain-containing proteins (Fig. 4.13 A); however, the first and third GXXG motifs did not 
have these additional conserved sequences.  Moreover, these amino acids are conserved in 
DDX43 orthologues across species as well (Fig. 4.13 B).  To experimentally confirm that the 
second GXXG motif containing region is a real KH domain, we cloned this region (69-142 
aa, named DDX43KH) into a pET28 vector, and purified this protein to near homogeneity (Fig. 
4.14 A).  Using the 19 bp forked duplex DNA substrate, EMSA revealed  
41 
 
 
 
Figure 4.12 Purification and characterization of the DDX43 N-terminal domain.  (A) 
Schematic representation of full length DDX43 and DDX43 N-terminal (top), and purified 
proteins (N-terminal wild type and mutants, 1 µg each) shown on Coomassie stained SDS-
PAGE gel (bottom).  (B-E) Representative EMSA images for binding of potential different 
KH domains in the N-terminal of DDX43 with 0.5 nM 19 bp forked duplex DNA (B) 5’ tail 
13 bp duplex RNA (C) dT30 ssDNA (D) or 30 bp blunt end dsDNA (E).  The proteins at 
various concentrations (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM) were incubated with DNA or RNA 
substrates, and nucleic acids-protein complexes were resolved on native 5% polyacrylamide 
gels.  
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that DDX43KH bound DNA similar to or even tighter than wild-type protein (Fig. 4.14 B); 
however, the G84D mutation in the KH domain (DDX43KH(G84D)) abolished its binding 
activity.  Similar results were obtained with a 5’ tailed RNA substrate as well as ssDNA and 
ssRNA (Fig. 4.14 C, D and E).  However, none of them bound blunt-end dsDNA (Fig. 4.14 
F).  Collectively, we concluded that the second GXXG motif-containing region is a functional 
KH domain and is involved in nucleic acid binding in DDX43. 
 
 
Figure 4.13 KH domain alignment.  (A) KH domain sequences of human hnRNP K, FMR1, 
NOVA and SF1 are aligned with the KH domain sequence of DDX43.  (B) KH domain 
alignment of DDX43 orthologous species.  The KH domain signature sequence in the middle 
of the domain is outlined.  Numbers on the left indicate positions of the initial amino acid of 
the KH domain.  Highly conserved positions are highlighted, and gaps are introduced for 
optimal alignment. 
 
hnRNP K (1) 41... EMVELRILLQSKNAGAVIGKGGKNIKALRTDYNASVSVPDSSGPERI------LSISADIETIGEI
hnRNP K (2) 143.. FDCELRLLIHQSLAGGIIGVKGAKIKELRENTQTTIKLFQECCPHSTDR---VVLIGGKPDRV
hnRNP K (3) 386.. PIITTQVTIPKDLAGSIIGKGGQRIKQIRHESGASIKIDEPLEGSED----RIITITGTQDQIQ
FMR-1   (1) 40... SRFHEQFIVREDLMGLAIGTHGANIQQARKVPGVTAIDLDEDTCT--------FHIYGEDQDAVKKAR
FMR-1   (2) 217.. EFAEDVIQVPRNLVGKVIGKNGKLIQEIVDKSGVVRVRIEAENEKNVPQEEEIMPPNSLP
NOVA    (1) 280.. GEYFLKVLIPSYAAGSIIGKGGQTIVQLQKETGATIKLSKSKDFYPGT-TERVCLVQGTAE
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Homo sapiens        67..PLCFALKSHFVGAVIGRGGSKIKNIQSTTNTTIQIIQEQPESLVKIFGSKAMQTKAKAVIDNFVKKEENYNSE 
Macaca mulatta      67..PLCFALKNHFVGAVIGRGGSKIKNIQSTTNTTIQIIQEQPESLVKIFGSKAMQTKAKAAIDNFVKKEENYNSE 
Pan troglodytes     67..PLCFALKSHFVGAVIGRGGSKIKNIQSTTNTTIQIIQEQPESLVKIFGSKAMQTKAKAVIDNFVKKEENYNSE 
Rattus norvegicus   66..PLCFGVKNDVVGAVIGRGGSKIREIQNTTNTRIQVIKGNPEAEIKIFGNKAMQTKAKTVIDNVVKKQQNYIPG 
Mus musculus        66..PLCFGVKNDVVGAVIGRGGSKIREIQNTTNTRIQVIKGNPEAEIKIFGNKAMQTKAKTVIDNVVKKQQNYIPG 
Felis catus         67..PLCFGLKNMWVGAVIGRGGSKIKDIQSTTNTKIQIIKGYPDAQVRIFGSKGMKAKAKTAIDNVVKQQESYSLK 
Bos Taurus          67..PLSFKLKNDCVGAVIGRGGSNIKEIQSSTYTKIQIIRGYPEAEVRIFGTKAMQSKAKTVIDDLVKKQEEYKTE 
Sus scrofa          67..PLSFRLKNDWVGVVIGRGGSKIKEIQNTTYTKIQIIKGYPEAEVRIFGTEEMQSKARIVIDNIVKKQEEYKSE 
Ovis aries          67..LLSFKLKNDCVGAVIGRGGSNIKEIQSSTYTKIQIRRGCPEAEVRIFGTKAMQCKAKTVIDDLVKKQEEYKTE 
Gallus gallus       77..PLCFLISSALAGVLIGRGGAKIKELEESSGSRIQVIKGTSEAEVKIFGSAAVQNKAKVLIDETVVSCGQSNPR 
Anolis carolinensis 63..PLCFHLDNALVGALIGRGGSRIKELEDSSGCKIKVMRGDYEAEVKVFGDNDKKRKAKMLIDDLIDRAKQSSAG  
Danio rerio        100..SVTLNVENSLVGRIIGRGGAKIRELQESSGASIKAI--ITRGEVLICGSCDAQHKAKDMIEDLVHEMGGSGYR 
            
 
 
 
 
 
 
 
 
 
 
 
 
L
V
I
V
A
S
A
I V
I
I
V
GGRGGConsensus GA
R
I KAKV
L
I
I K
N
I
L
GXXG
43 
 
 
 
Figure 4.14 Purification and characterization of the DDX43 KH domain.  (A) Schematic 
representation of full-length DDX43 and its KH domain (top), and purified KH domain 
proteins (wild type and mutant, 1 µg each) shown on Coomassie stained SDS-PAGE gel 
(bottom).  (B-F) Representative EMSA images for KH domain proteins binding with 0.5 nM 
of 19 bp forked duplex DNA (B), 5’ tailed dsRNA (C) dT30 ssDNA (D), ssRNA rU30 (E), 
and blunt-end dsDNA (F). The proteins at various concentrations (0.09, 0.18, 0.37, 0.75, 1.5, 
3 µM) were incubated with DNA or RNA substrates, and nucleic acids-protein complexes 
were resolved on native 5% polyacrylamide gels. 
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4.9.2 The N terminal domain has Strand Exchange Activity 
It has been reported that the KH domain-containing fragile X mental retardation protein 
(FMRP) has strand exchange activity and the presence of KH domains play a critical role for 
this activity (Gabus et al., 2004).  Thus, we asked whether DDX43 possesses this nuclear 
chaperone property or not.  Indeed, with unlabeled cold oligo D26 in the reaction the N-
terminal domain (DDX43NT) displayed strand exchange activity on a 19-bp forked duplex 
DNA substrate in a concentration (0 to 3 µM) dependent manner, while the N-terminus (1-
253aa) mutant G84D (DDX43NT(G84D)) did not show this activity (Fig. 4.15).  
 
 
 
Figure 4.15 Strand exchange activity of DDX43 N-terminal domain.  Strand exchange 
activity was examined by incubating 19 bp forked dsDNA and unlabeled cold oligo with 
DDX43NT or DDX43NT (G84D) (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM). Filled triangle, heat 
denatured substrate control. 
 
4.9.3 The N-terminal domain is required for the Unwinding Activity 
The unwinding activity of the DEAD-box family proteins is only confined to the helicase 
core.  As previous results showed that DDX43NT (1-253aa) of DDX43 possesses strand 
exchange activity, we aimed to examine if this KH domain containing N-terminus also 
possesses unwinding activity.  Thus, I evaluated the unwinding activity of DDX43NT using a 
19bp forked DNA substrate in concentration-dependent manner (0 to 3 µM) and found that it 
could unwind the substrate but with less efficiency as compare to the DDX43 full length 
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protein, while mutant DDX43NT(G84D) did not show this activity (Fig. 4.16 A).  Furthermore, 
we found that the unwinding activity of DDX43NT was ATP-dependent (Fig. 4.16 B).  In 
conclusion, I found that the DDX43NT has ATP-dependent strand exchange activity and is 
required for the full functionality of the protein for unwinding activity. 
 
 
Figure 4.16 Unwinding activity of the DDX43 N-terminal domain.  (A-B) Unwinding 
activity was examined by incubating 19 bp forked dsDNA with DDX43NT or 
DDX43NT(G84D) (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM).  (A) Helicase activity was examined by 
incubating a 19 bp forked dsDNA with DDX43NT or DDX43NT(G84D) (0.09, 0.18, 0.37, 0.75, 
1.5, 3 µM) (B). Helicase activity of DDX43NT was examined by incubating a 19 bp forked 
dsDNA with or without ATP. Filled triangle, heat denatured substrate control. 
4.10 The N-terminal domain and Helicase Domain Have Synergistic Effects 
on the Unwinding Activity of DDX43 Protein 
4.10.1 The Helicase Domain of DDX43 Possesses Weak Unwinding Activity 
Human Pif1 helicase has been shown to contain unwinding activity without its accessory 
domain (George et al., 2009).  Next, we asked whether the C-terminal helicase domain alone 
has unwinding activity and hence I purified the C-terminal helicase domain (254-648 aa, 
named HD) to near homogeneity (Fig. 4.17 A).  Using a 19-bp forked duplex DNA substrate, 
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I detected unwinding for the HD protein in a concentration-dependent manner (0-3µM); 
however, it was very weak compared to the full-length protein (Fig. 4.17 B), suggesting the 
helicase domain cannot function independently. 
 
 
Figure 4.17 Unwinding activity of the DDX43 helicase domain.  (A) SDS-PAGE analysis 
of the DDX43 helicase domain proteins eluting from a Sephacryl S-300 HR column. 1 μg 
was loaded.  (B) Representative images of helicase reactions by incubating increasing 
DDX43HD protein (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM) with 0.5 nM a 19 bp forked dsDNA. 
Filled triangle, heat denatured substrate control.  
 
4.10.2 The N-terminal Domain and Helicase Domain of DDX43 Unwind 
Substrates Synergistically 
Since the DDX43 protein unwinds RNA duplexes with a nonprocessive mechanism and DNA 
duplexes with a processive mechanism, we suspected that the helicase core domain may be 
responsible for this phenomenon (Singleton et al., 2007).  Then we asked whether the N-
terminal domain (DDX43NT, 1-253 aa) and helicase domain (DDX43HD, 208-648 aa) can 
work synergistically for unwinding.  With an increasing concentration of DDX43NT and 
DDX43HD proteins (1:1 ratio), we observed increased unwinding on a DNA substrate (Fig. 
4.18 A); however, it is still lower than the full-length DDX43 protein (Fig. 4.3 A).  For 
instance, at the highest concentration (3 µM), the full-length DDX43 protein could unwind 
~75%, while the combined DDX43NT and DDX43HD proteins unwound ~50%, with 
DDX43NT contributing ~40%, and DDX43HD contributing~10% (Fig. 4.18 B).  Taken 
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together, these results suggest that the DDX43NT (1-253 aa) binds nucleic acids independent 
of its C-terminal DDX43HD (254-648 aa), while the C-terminal helicase domain requires N-
terminal domain (1-253 aa) for its full activity. 
 
 
 
Figure 4.18 Synergistic unwinding activity of the DDX43 helicase domain and the N-
terminal domain.  Synergic helicase activity of DDX43HD and DDX43NT was examined by 
incubating 0.5 nM a 19 bp forked dsDNA with both truncated proteins (0.09, 0.18, 0.37, 0.75, 
1.5, 3 µM). Filled triangle, heat denatured substrate control. 
 
4.11 The KH Domain of Sam68 Does Not Have a Synergistic Effect with the 
DDX43 Helicase Domain on Unwinding 
4.11.1 The KH domain of Sam68 Protein Binds both DNA and RNA 
Substrates. 
The Src associated substrate in mitosis of 68kDa, Sam68, is an RNA-binding protein which 
belongs to the STAR (signal transduction and activation of RNA metabolism) family of RNA-
binding proteins (Lukong and Richard, 2003).  To determine whether the strand exchange and 
unwinding activity of the N-terminal domain (DDX43NT-1-253aa) from DDX43 are unique, 
we cloned the KH domain of Sam68KH (97-208 aa) into NdeI/XhoI sites of pET28a vector, 
overexpressed it in E. coli. and purified by two-step chromatography.  The Sam68KH protein 
was purified to near homogeneity (Fig. 4.19 A) and an EMSA assay revealed that it bound 
both 19 bp dsDNA and ssRNA molecules (Fig. 4.19 B and C).  
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Figure 4.19 Purification and characterization of the KH domain from Sam68.  (A) SDS-
PAGE analysis of Sam68 KH domain protein eluted from a Sephacryl S-100 HR column.  
(B,C) Representative EMSA images for Sam68 KH proteins binding with 0.5 nM 19 bp 
forked duplex DNA (B) and 30 mer random RNA substrate (C). The proteins at various 
concentrations (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM) were incubated with DNA or RNA 
substrates, and nucleic acids-protein complexes were resolved on native 5% polyacrylamide 
gels. 
 
4.11.2 The KH Domain of Sam68 Shows Weak Unwinding on DNA but No 
Unwinding on an RNA Substrate, and no Synergistic Effect. 
As showed in the previous results, DDX43NT (1-253 aa) possesses unwinding activity. Thus 
next we aimed to examine if an unrelated KH domain in the Sam68 protein (97-208 aa) 
possesses any helicase activity.  Using a 19-bp forked duplex DNA substrate, unexpectedly 
we found that the KH domain of Sam68 displayed some unwinding activity on DNA substrate 
(Fig. 4.20 A), though it was less active than DDX43NT.  In contrast, Sam68KH exhibited no 
unwinding activity on a 13 bp duplex RNA substrate (Fig. 4.20 B).  Because the DDX43 
helicase domain has weak unwinding activity, which is enhanced in the presence of the N-
terminal domain (1-253 aa) in a synergistic manner, we asked whether the KH domain of the 
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N-terminal shows any synergy with the helicase domain of DDX43.  However, no such 
synergy was observed in the presence of the KH domain of Sam68 for unwinding of the 
substrate (Fig. 4.20 C). 
 
 
Figure 4.20 Unwinding assays of the Sam68 KH domain protein.  (A-B) Representative 
helicase assay for Sam68 KH protein with 19 bp forked duplex DNA with and without ATP 
(A) and 5’ tailed 13 bp RNA duplex substrate with ATP (B).  (C) Helicase activity of 
DDX43HD and Sam68KH was examined by incubating 0.5 nM 19 bp fork duplex DNA with 
both proteins (0.09, 0.18, 0.37, 0.75, 1.5, 3 µM). Filled triangle, heat denatured substrate 
control. 
 
4.12 Overexpression of DDX43 Protein in Triple-Negative Breast Cancer 
Cell Lines and Tissues 
TNBC is a heterogeneous disease, with the poorest prognosis among the different subtypes 
of breast cancer.  At the moment, no standard targeted therapies exist against TNBC.  Our 
immunohistochemistry (IHC) data suggest that the expression of DDX43 varies among tumor 
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grade and malignancy, but not necessary according to molecular class even though  
 
 
Figure 4.21 The expression of DDX43 in breast cancer cell lines and tissues.  (A) Western 
blot analysis of DDX43 protein expression in indicated breast cell lines. DDX43 antibody is 
SAB1400618 (Sigma), actin is A5441 (Sigma).  A 15-well gel was used for left blot, 10-well 
for right.  (B) DDX43 expression in different stages of breast cancer tissues, adjacent cells 
are used to describe non-invasive breast cancers.  Stage I to IV all describe invasive breast 
cancer.  Some of them showed in the figure are divided into subcategories known as IIA, IIB, 
IIIA and IIIB. Immunohistochemistry was done by US Biomax.  (C) DDX43 expression in 
subtypes of breast cancer tissues.  Immunohistochemistry was done by US Biomax. 
TNBC seems to express higher levels of DDX43.  Like primary tumors, there is significant 
variability amongst breast cancer cell lines based on a number of criteria including gene 
expression profile, molecular class, subtype, tumorigenicity and metastasis (Neve et al., 
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2006).  To further delineate the significance of DDX43 and triple negative status in breast 
cancer progression, we evaluated the expression levels among a panel of cell lines 
representing a spectrum of breast cancer phenotypes. ER+: MCF7, T47D and MDA-MB-
134VI, HER+: AU565, SKBR3 and HCC202; TNBC: MDA-MB-231, BT20, and HCC 1395; 
normal breast cell line: MCF 10A, MCF 10F, MCF 12A, and 184 B5. DDX43 protein 
expression was detected in MCF 7 of ER+, AU 565 and SKBR3 of HER+, and all three cell 
lines of TNBC, while low expression in normal cell line MCF 10A and MCF 12A, and absent 
in MCF 10F and 184 B5 (Fig. 4.21 A).  These results indicate that DDX43 is consistently 
expressed in TNBC cell lines.  Thus we expanded the TNBC cell line pool, including BT549, 
HCC 1395, HCC 38, HCC 1806, HCC 1937, HS 578T, and HCC 1187, along with normal 
cell line MCF 10A, we found that DDX43 is expressed in most of the TNBC.  Taken together, 
we concluded that DDX43 protein is consistently and highly expressed in TNBC cell lines. 
 
4.13 DDX43 Interacts with Proteins that are involved in Pre-mRNA 
Splicing 
To explore the possible biological function of DDX43 in cells, I performed 
immunoprecipitation by overexpressing DDX43 in HEK-293T cells (Fig. 4.22 A) and 
potential proteins associated with DDX43 were identified by mass spectrometry at the 
University of Alberta.  Our preliminary results suggested that DDX43 interacts with MEP50 
and pICln (Table 4.1).  Their interactions were further confirmed by the presence of pIcln in 
the HEK293T pull down lysate using antibody against pIcln (1:1000, cat# sc-271454, Santa 
Cruz) (Fig. 4.22 B).  MEP50 and pICln are two subunits of the pre-mRNA splicing complex 
(Friesen et al., 2001), thus DDX43 might be involved in pre-mRNA splicing; nevertheless, 
their physical and functional interaction with DDX43 needs further investigation. 
52 
 
  
Figure 4.22 Immunoprecipitation of DDX43 and its interacting proteins.  (A) Silver-
stained SDS gel showing overexpressed DDX43 pull-down from HEK293T cells.  The 
Overexpressed DDX43 band is indicated by an asterisk and the potential DDX43-associated 
protein by arrows.  (B) Western blot image of pICln (sc-271454, Santa Cruz) using 
HEK293Tpull down lysate.  Note: the predicated size of pICln is 26.2 kDa, but it is about 37 
kDa on SDS-PAGE gel. 
Table 4.1 Peptide identification by mass spectrometric in-gel digestion analysis 
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P54105 Methylosome subunit pICln OS=Homo sapiens GN=CLNS1A 
PE=1 SV=1 - [ICLN_HUMAN]
26.80 15.92 5 26.2
Q9BQA1 Methylosome protein 50 OS=Homo sapiens GN=WDR77 PE=1 
SV=1 - [MEP50_HUMAN]
16.62 12.94 4 36.7
P05388 60S acidic ribosomal protein P0 OS=Homo sapiens GN=RPLP0 
PE=1 SV=1 - [RLA0_HUMAN]
13.10 13.88 3 34.3
P22626 Heterogeneous nuclear ribonucleoproteins A2/B1 OS=Homo 
sapiens GN=HNRNPA2B1 PE=1 SV=2 - [ROA2_HUMAN]
10.74 10.55 2 37.4
P29692 Elongation factor 1-delta OS=Homo sapiens GN=EEF1D PE=1 
SV=5 - [EF1D_HUMAN]
6.67 17.79 3 31.1
P31942 Heterogeneous nuclear ribonucleoprotein H3 OS=Homo 
sapiens GN=HNRNPH3 PE=1 SV=2 - [HNRH3_HUMAN]
6.44 10.40 3 36.9
Q9UKM9 RNA-binding protein Raly OS=Homo sapiens GN=RALY PE=1 
SV=1 - [RALY_HUMAN]
5.21 5.88 2 32.4
Q96DI7 U5 small nuclear ribonucleoprotein 40 kDa protein OS=Homo 
sapiens GN=SNRNP40 PE=1 SV=1 - [SNR40_HUMAN]
4.65 4.48 2 39.3
Q8N954 G patch domain-containing protein 11 OS=Homo sapiens 
GN=GPATCH11 PE=1 SV=3 - [GPT11_HUMAN]
4.64 8.88 2 30.2
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5. Discussion  
In this study, we have found that DDX43 is an ATP-dependent helicase which could unwind 
both RNA and DNA substrates, as a dual helicase.  It catalyzes the unwinding reaction most 
efficiently in the presence of Mg2+ and ATP. Intriguingly, for unwinding RNA substrates, 
DDX43 does not follow any strict translocation mechanism, but it unwinds DNA in a 
unidirectional manner.  We also found that the KH domain in the N-terminal region is 
involved in nucleic acid binding.  Surprisingly, the N-terminal domain in the DDX43 exhibits 
both strand exchange activity and unwinding activity, and synergy between the N-terminal 
and C-terminal domains of DDX43 is essential for its full unwinding activity.  To gain insight 
into its cellular function, we found that DDX43 interacts with the proteins involved in pre-
mRNA splicing, indicating its potential role in RNA metabolism in cells. 
 
5.1 DDX43 is an ATP-dependent Dual Helicase  
The majority of known helicases specifically unwind only one type of duplex, either DNA or 
RNA, but the basis of this discrimination is unknown.  DEAD-box family proteins exhibit 
characteristic RNA helicase activity (Jarmoskaite and Russell, 2011); however, there are some 
exceptions within the family.  For example, the hepatitis C viral NS3 protein is a processive 
DNA helicase, but can also unwind RNA in the presence of cofactor NS4A (Pang et al., 2002). 
p68, a characteristic RNA helicase also shows unique dual helicase activity (Tuteja et al., 
2014).  Another DEAD-box RNA helicase Dbp9p exhibits DNA-DNA and DNA-
RNA helicase activity in the presence of ATP (Kikuma et al., 2004).  These reports suggest 
that the DEAD-box family includes proteins with a wide variety of biochemical activities. 
DDX43 is classified as a DEAD-box family protein based on sequence homology to 
the SF2 superfamily.  RNA unwinding activity has been reported for DDX43 protein (Linley 
et al., 2012).  We started the biochemical characterization of DDX43 protein and the results 
demonstrated that it could unwind RNA, DNA and RNA:DNA hybrids as well in an ATP-
dependent manner.  Similar to other DEAD-box RNA helicases, DDX43 displays a limited 
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processivity on duplex RNA, but a comparatively high processivity on duplex DNA, which 
makes DDX43 a new entry in the list of dual helicases with unique characteristics. 
 
5.2 DDX43 is a Non-processive RNA Helicase 
Processivity is most often defined as the average number of base pairs unwound per helicase 
binding event, ranging from tens to tens of thousands of base pairs.  A highly processive 
helicase rarely dissociates during unwinding and is thus able to perform many consecutive 
unwinding steps.  A helicase that dissociates more often displays lower processivity and 
unwinds fewer base-pairs per binding event (Lohman et al., 2008). Because, unlike most 
helicases, the efficiency of strand separation for these proteins is strongly dependent on the 
stability of the helix, not just its length. 
 In general, RNA helicases usually have low processivity on the substrate. Rogers et 
al., showed that eIF4A, a prototypical member of the DEAD-box family, acts in a non-
processive manner (Rogers, Jr. et al., 1999).  They proposed that the initial rate of duplex 
unwinding and the maximum amount of duplex unwound decreased with increasing stability 
of the duplex RNA substrate.  RhlE has also been found to have low processivity as the ratio 
(duplex unwound)/ (ATP hydrolyzed) drops 1000-fold upon going from 11 to 14 base pairs 
(Bizebard et al., 2004).  Almost all members of the DEAD-box family studied so far appear 
similar to eIF4A and RhlE, and show little or no processivity.  This includes DDX1 (10 bp) 
(Kellner et al., 2015), DDX20 (15 bp) (Yan et al., 2003) and DDX25 (20 bp) (Tang et al., 
1999).  Only p68 (162 bp) and p72 (36 to 46 bp) were shown to unwind moderately long RNA 
duplexes (Hirling et al., 1989; Rossler et al., 2001).  
 However, it should be noted that reaction conditions, such as the amount of substrate 
and protein concentration, duration of reaction, amount of ATP, and so on, may cause the 
difference reported.  Even in the case of DDX43, it has been reported it could unwind 40 bp 
duplex RNA when different reaction conditions were used (Linley, Mathieu et al. 2012).  
Nevertheless, most of the DEAD-box helicases have limited processivity. 
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In our study, we have found that DDX43 could efficiently unwind 13 bp dsRNA but 
not 16 bp dsRNA, suggesting that DDX43 is a low processivity DEAD-box protein.  It should 
also be noted that exclusive RNA duplex structures exist mainly during viral replication and 
transcription.  Helical elements within structured RNAs are rarely longer than 10 base pairs 
(Jankowsky and Fairman, 2007).  Thus, there appears to be little need for highly processive 
RNA helicases.  
 
5.3 DDX43 Unwinds RNA duplexes by a Mode Distinct from Translocating 
Helicases 
Helicases translocate in one direction along the loading strand of DNA or RNA in an ATP-
driven manner, thereby displacing either complementary nucleic acids or bound proteins 
(Mackintosh and Raney, 2006).  However, most DEAD-box proteins show bidirectional 
unwinding.  This lack of directionality is unique when compared with other families within 
SF2 or with other superfamilies.  Most DEAD-box proteins unwind substrates without any 
preference for the polarity of single-stranded overhangs and unwind duplexes by local strand 
separation.  
DEAD-box protein Ded1 has been shown to unwind RNA duplexes irrespective of 
the orientation of single-stranded regions, and it could also unwind blunt-end duplexes 
although this reaction proceeded at a substantially slower rate (Yang and Jankowsky, 2006).  
Further additions to this list are DEAD-box RNA helicase proteins p68 (Huang and Liu, 
2002), eukaryotic initiation factors eIF-4A (DDX2) (Rozen et al., 1990), DDX25 (Tang et al., 
1999), Has1p (Rocak et al., 2005), and SRMB (Bizebard et al., 2004), which can unwind 
dsRNA in both 3’-5’ and 5’–3’ direction, regardless of the orientation of the single-stranded 
regions.  This distinct unwinding mode of DEAD-box proteins appears uniquely suited for 
the localized separation of short duplexes in the cell.  First, usually short duplex RNAs, no 
longer than 10 bp, are present in cells (Mallam, Del Campo et al. 2012).  Second, the structure 
of Mss116p with RNA revealed that a single protein monomer could bind along most of the 
56 
 
length of U10 RNA; raising the possibility that strand separation by DEAD-box proteins does 
not involve any translocation at all (Del Campo and Lambowitz 2009) 
In our study, we found that the DDX43 can unwind the blunt end RNA substrate, 
suggesting that the unwinding could begin internally.  However, DDX43 is more active on 
5’tailed than 3’tailed dsRNA substrates, but the mechanism remains unknown.  A very recent 
study reported that the Ski2-like RNA helicase Mtr4p unwinds RNA duplexes by 3’ to 5’ 
translocation (Patrick et al., 2016), suggesting some RNA helicases may unwind RNA 
duplexes by translocation-based mechanisms.  This property of DEAD-box helicases can be 
related to their role in RNA metabolism as duplex unwinding without translocation on the 
loading strand may be prevalent in RNA metabolism.  These results raise the possibility that 
many DEAD-box proteins may not function as directional motors, but as “strand separation 
switches”.  Unwinding RNA structures by loading the helicase directly onto the duplex and 
then “switching” the two strands apart, may be well suited for enzymes that encounter mostly 
short duplexes within large RNP assemblies. 
 
5.4 DDX43 Unwinds a DNA substrate in a 3’ to 5’ Direction by a 
Translocation Mechanism 
Most of the superfamily2 (SF2) helicases possess 3’ to 5’ directionality on a DNA substrate 
(Buttner et al., 2007).  The conserved domains of SF2 helicases consistently bind nucleic acid 
strands with a defined polarity which assures the unwinding reaction to be in a 3’ to 5’ 
direction.  Helicase domain 1 (Rec A1) interacts with the 3’ end and helicase domain 2 (Rec 
A2) interacts with the 5’ end of bound single strands, resulting in an interface with a well-
defined asymmetry that is likely to differentiate the two possible strand orientations within 
the binding cleft (Hopfner and Michaelis, 2007).  Furthermore, the beta-hairpin that projects 
from helicase domain 2 of SF2 helicases NS3 and Hel308 have been found to reinforce the 
directional geometry and stimulates unwinding in 3’ to 5’ direction (Myong et al., 2007).  It 
has been shown that Plasmodium cynomolgi DEAD-box DNA helicase 45 (PcDDH45), an 
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ATP-dependent DNA-unwinding enzyme, translocates in the 3’ to 5’ direction to unwind the 
substrate.  Intriguingly, in our study, we found that DDX43 unwinds the DNA substrate by a 
conventional canonical mechanism, that is, in a defined 3’-5’ direction.  It has been found 
that the helicase core domains, HD1 and HD2 in Mss116p DEAD box helicase, have modular 
functions enabling a novel mechanism for RNA-duplex recognition and unwinding where D1 
binds ATP and D2 contains a nucleic acid-binding pocket, which accommodates A-form but 
not B-form duplexes (Mallam et al., 2012).  Also, the crystal structure of Msp116 with ssDNA 
and ssRNA revealed that the protein forms a closed-state complex with both nucleic acids. 
Although the interactions are similar, the closed-state complex with ssRNA contains protein 
contacts to the RNA 2’-OH groups that are absent in the closed-state complex with ssDNA 
(Mallam et al., 2014).  This provides a basis for substrate specificity and might explain the 
differential unwinding mechanisms on RNA and DNA substrates.  Nevertheless, to further 
address the different unwinding mechanisms of DDX43 on RNA and DNA, we will solve its 
crystal structure with nucleic acids bound, and perform mutagenesis studies to identify amino 
acids involved in the polarity.  
Most DNA helicases use translocase mechanisms to unwind the substrate, and for 
translocases processivity is a major aspect of their activity, because their primary function is 
to walk along nucleic acids.  A high degree of processivity is crucial for helicases involved in 
DNA replication, where millions of base pairs must be replicated quickly (Rajagopal and 
Patel, 2008).  In our study, we found that DDX43 is processive on the DNA substrate 
compared to that of on the RNA substrate as it could unwind forked dsDNA substrate even 
up to 40 bp in length.  However, the rate of duplex unwinding is significantly decreased with 
increasing length of the duplex, which is different from classic DNA helicases.  A key 
property of DNA helicases is their ability to unwind long duplexes.  Certain DNA helicases 
(e.g., MCM (Lee and Hurwitz, 2001), RecBCD (Bianco et al., 2001), TraI (Lahue and 
Matson, 1988) can processively unwind DNA tracts with longer than 500 base pairs.  Even 
on a preferred forked duplex DNA substrate, DDX43 acts inefficiently to unwind a 50 bp 
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duplex, suggesting that DDX43 is specifically tailored to act on short duplex substrates, which 
might occur in DNA repair or replication restart. 
 
5.5 The KH domain in the N-terminus of DDX43 is Responsible for Nucleic 
Acid Binding 
In eukaryotes, RNA-binding proteins that contain multiple K homology (KH) domains play 
a key role in coordinating the different steps of RNA synthesis, metabolism and localization 
(Hollingworth, Candel et al. 2012).  Both in eukaryotes and prokaryotes KH domains interact 
with their single-stranded nucleic acids targets with different affinity and specificity and they 
have been shown to recognize up to four nucleotides, although non-specific contacts can be 
made with additional flanking nucleotides.  KH3 domain in Nova2 has been found to show 
sequence specific RNA binding (Lewis, Musunuru et al. 2000).  The highly conserved GXXG 
loop in the KH domain has a specific sequence element that establishes contact with the 
nucleic acid, which is essential for the biochemical function of the protein (Valverde et al., 
2008).  KH domains fold as a three stranded anti-parallel β-sheet on the surface of which pack 
three α-helices.  ssNA binding is mediated by a hydrophobic groove or cleft formed on one 
side by two short consecutive α -helices (α 1 and α 2) and the intervening GxxG loop and, on 
the other side, by the inner surface of the domain’s β -sheet and the attached variable loop 
(Musco, Stier et al. 1996) (Fig. 1.4 B) . 
The KH domain has been found in a variety of RNA-binding proteins but, no helicase 
protein is known to contain this domain to date.  KH domains bind RNA or ssDNA, and are 
found in proteins associated with transcriptional and translational regulation, along with other 
cellular processes.  Several diseases, e.g. fragile X mental retardation syndrome and 
paraneoplastic disease, are associated with the loss of function of a particular KH domain.  
Mutation in the hallmark GxxG loop has been found to impair nucleic acid binding of the 
protein (Hollingworth et al., 2012; Chmiel et al., 2006).  A single amino acid substitution 
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(I304N) in this consensus sequence of the FMR1 protein affects its RNA-binding properties 
and causes fragile X mental-retardation syndrome (De et al., 1993). 
In our study, sequence alignment revealed that DDX43 contains one KH domain, 
which has the signature VIGXXGXXI motif in the middle of the domain (Fig. 4.13 A and 
B).  Site-directed mutation of glycine at position 84 in the 84-GXXG-87 motif abolished the 
nucleic acid binding ability of the KH domain.  Moreover, a single amino acid mutation 
DDX43KH(G84D), has significant reduced unwinding activity, indicating the KH domain in 
DDX43 is responsible for nucleic acid binding. 
 
5.6 The N-terminus of the DDX43 Protein possesses Novel Strand Exchange 
Activity  
Many helicases have been found to possess strand exchange activity including helicases PIF1 
(Gu et al., 2008) and mitochondrial helicase TWINKLE (Sen et al., 2016).  Interestingly some 
non-helicase proteins also possess strand exchange activity as well.  The fragile X mental 
retardation protein has been found to have strand exchange activity and the presence of KH 
domains play a critical role for this activity (Gabus et al., 2004).  Our results indicated that 
N-terminus of DDX43 possesses strand exchange activity and it is require for full 
functionality of the protein.  Because the KH domain is able to bind ssDNA or ssRNA, like 
ssDNA binding protein RPA and POT1, which have been reported to melt dsDNA and dsRNA 
(Ahn et al., 2009), we believe that the KH domain in DDX43 may have similar duplex 
destabilizing activity.  However, it remains unknown why ATP is required in this reaction.  To 
investigate whether the strand exchange activity is a universal property for KH domain, we 
are examining the enzymatic activities of KH domain from DDX53 helicase and Sam68 
protein. 
 
60 
 
5.7 Synergistic Effect of the N-terminal domain and the Helicase domain on 
Unwinding 
Several DEAD-box helicases possess ancillary N- and C-terminal domain(s) that are involved 
in mediating specificity and/or affinity for RNA/DNA substrate (Samatanga and 
Klostermeier, 2014).  It has been reported that DEAD-box helicases bind to helix extensions 
with low or no specificity, but the ancillary domains help in target recognition and thus 
unwinding.  In DEAD-box proteins DbpA (E. coli) and its B. subtilis homolog YxiN, the C-
terminal domain alone is sufficient to confer specificity for 23S rRNA (Karginov et al., 2005).  
However, for full functionality, it combines the activities of the helicase domain and the C-
terminal domain.  The C-terminal domain of DbpA recognize a hairpin in the ribosomal 23S 
rRNA with high affinity and specificity and has been implicated in ribosome biogenesis (Fan 
et al., 2009; Fuller-Pace et al., 1993).  The helicase core of DEAD-box protein Dbp5/DDX19 
is flanked by an N-terminal extension which has been found to contribute to nucleotide 
binding, a homologous region is also found in DDX25 (Fan et al., 2009).  The DEAD box 
protein Hera from Thermus thermophiles has been found to contain a flanking C-terminal 
region to the helicase core, which consists of a dimerization motif and RNA binding domain 
that mediates high affinity interaction with ribosomal RNA fragments and RNase P RNA 
(Linden et al., 2008). 
In our study we have found that the N-terminal domain of DDX43 plays an important 
role in the full activity of the protein.  The C-terminal helicase domain has very low 
unwinding activity and unwinding activity was significantly increased through synergy 
between the N-terminal domain and the helicase domain.  The truncated protein, i.e. the C-
terminal helicase domain, did not show any unwinding activity on RNA and had very weak 
melting activity on DNA, indicating that the KH domain is more crucial for DDX43 to 
perform unwinding activity on RNA substrate, which is consistent with the notion that KH 
domain is a RNA binding domain (Nicastro et al., 2015b).  More studies are required to 
determine the structural and functional role of KH domain in DDX43 helicase, for example, 
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whether the KH domain dictates the sequence specific recognition of substrates for DDX43 
helicase, and/or stimulates the unwinding activity of helicase core domain by binding 
ssRNA/DNA to prevent them reannealing.  
 
5.8 Overexpression of DDX43 in Breast Cancer Cell Lines and Tissues 
Breast cancer is the most common and leading cause of cancer deaths in women.  Despite the 
improved outcomes that have been achieved by earlier detection and recent advances in 
therapy, recurrence still occurs in over 20% of patients (Gluck and Mamounas, 2010); (Dotan 
and Goldstein, 2010).  It is therefore becoming increasingly important to identify biomarkers 
that can aid in assessing a patient's risk and response to therapy and which might also act as 
novel targets for immunotherapies (Harris et al., 2007; Harbeck et al., 2010). 
DDX43 was first identified in a sarcoma cell line using representational difference 
analysis (Martelange et al., 2000).  DDX43 was subsequently shown to be expressed in many 
haematological and solid tumour samples but not in any of the normal tissues tested, except 
the testis (Mathieu et al., 2010), thus classified as a Cancer Testis Antigen (CTA).  DDX43 
has been found as a biomarker for poor prognosis and a predictor of chemotherapy response 
in breast cancer and its expression is also correlated with the progression of TNBC (Abdel-
Fatah et al., 2014).  It has also been shown that HAGE promotes tumor cell proliferation by 
regulating NRAS protein expression by unwinding and stabilizing NRAS mRNA and 
enhancing its transcription, which in turn leads to the activation of downstream signaling 
pathways AKT phosphorylation through the PI3K pathway and ERK phosphorylation 
through the RAF/MEK pathway, implicated in cell proliferation and survival (Linley et al., 
2012b).  Thus the tumor-specific expression and oncogenic role of DDX43 in cancer make it 
a potential target for breast cancer treatment. 
In our study, we have found that DDX43 has tumor-specific expression. It expresses 
minimally in the normal breast cell lines and tissues, and highly in TNBC cell lines and TNBC 
tissues.  Targeted therapies using the overexpression of a specific cancer cell membrane 
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molecule can facilitate the spatial and temporal delivery of therapeutics (Ovcaricek et al., 
2011).  Although identifying tumour-associated antigens that induce adaptive T-cell immunity 
is a prerequisite for establishing effective immunotherapy strategies, there is currently a lack 
of suitable candidates for the development of such treatments in BC.  In that scenario, DDX43 
can be used as a potential biomarker for treatment of TNBC. 
 
5.9 DDX43 might have a potential role in pre-mRNA splicing 
Pre-mRNA splicing is a multistep process that requires two trans-esterification reactions as 
well as many structural rearrangements of a large ribonucleoprotein complex: the 
spliceosome.  Methylosome subunit pICln is a chaperone that regulates the assembly of 
spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building 
blocks of the spliceosome.  Thereby, pICln plays an important role in the splicing of cellular 
pre-mRNAs (Neuenkirchen et al., 2008).  Methylosome Protein-50 (MEP-50) is a non-
catalytic component of the 20S PRMT5-containing methyltransferase complex, which 
modifies specific arginines to dimethylarginines in several spliceosomal Sm proteins and 
histones.  Using co-immunoprecipitation, our results revealed that both pIcln and MEP50 
interact with DDX43, indicating the potential role of DDX43 in the pre-spliceosome assembly 
of ribonucleoprotein in pre-mRNA splicing.  In fact, several DEAD-box RNA helicases have 
been found to be involved in the early events of the establishment of a functional pre-
spliceosome assembly.  These helicases have been implicated in RNA secondary structure 
rearrangements and protein displacement, allowing the spliceosome to assemble, rearrange 
and dissociate in a controlled manner.  In yeast, three DEAD-box proteins have been shown 
to be required for in vivo splicing including Sub2, Prp28 (DDX23) and Prp5 (DDX46) (Liu 
and Cheng, 2015).  The DEAD-box protein Prp28p appears to function in constitutive and 
alternative mRNA splicing, and its homolog p72 has been implicated in alternative splicing 
(Honig et al., 2002). 
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6. Conclusions and Future Work  
6.1 Conclusions  
In conclusion, we have found that DDX43 is an ATP-dependent dual helicase which can act 
on both RNA and DNA.  It follows translocation mechanism for unwinding DNA substrate; 
but it unwinds RNA substrate irrespective of the orientation of single-stranded tail.  A KH- 
domain present in the N terminus of DDX43 is involved in nucleic acid binding, and the N-
terminal domain possess unique strand exchange activity and helicase activity.  C-terminal 
helicase core domain and N-terminal domain work in a synergistic manner to unwind 
substrates.  DDX43 is highly expressed in both breast cancer tissues and breast cancer cell 
lines.  Interaction of DDX43 with pIcln and MEP-50 indicates its potential physiological 
functions in RNA metabolism. 
 
6.2. Future Work  
1) To determine the functional interaction of DDX43 and associated proteins in pre-
mRNA splicing.  Three approaches will be used for this experiment; 
a) Co-IP - Using the whole cell lysate with overexpression of FLAG tagged DDX43 
in MDA-MB-231 cells, and using DDX43 antibody (HPA031380, Sigma) 
(Endogenous Co-IP), potentially DDX43 interacting proteins pICln, MEP50, and 
PRMT5 will be determined.  
b) Immunofluorescence - DDX43, pICln, MEP50, and PRMT5 antibodies will be 
use to detect their co-localization in HeLa cells under confocal microscope. 
c) Overexpress GFP tagged DDX43 and MCherry tagged pICln, MEP50, or PRMT5 
in HEK293T cells, and their co-localization will be detected under confocal 
microscope. 
2) To study the role of DDX43 in oncogenesis, cell proliferation, migration, and tumor 
invasion will be detected in DDX43-deficient and DDX43-proficient cells.  For cell 
proliferation assays, “soft agar colony formation” will be used using the knockout cell 
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line and cell number will be determine using Beckman Coulter’s cell counter.  Transwell 
assay will be used for the cell migration. For cell invasion matrigel will be layered on the 
top of the well, after adding cell lines on matrigel and chemotactic factors will be added 
on the bottom and cell invasion will be studied through gel to the well. 
  
3) To examine the RNA splicing defect in breast cancer cell lines and to determine 
potential pre-mRNA splicing defect in DDX43-deficient cells, DDX43 konckout cells 
using CRISPR/cas9 technology will be generated.  The expression of DDX43 protein 
will be knock out in TNBC cell lines, including 1) MDA-MB-231, 2) BT20, 3) AU565, 
and 4) HCC135, and non-tumorigenic cell line MCF-10F will be used as a control. 
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